Advanced Search (OLGA)

Gene: GAREM1 (GRB2 associated regulator of MAPK1 subtype 1) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

GAREM1

Name:

GRB2 associated regulator of MAPK1 subtype 1

RGD ID:

1342843

HGNC Page

HGNC:26136

Description:

Enables proline-rich region binding activity. Involved in several processes, including cellular response to epidermal growth factor stimulus; epidermal growth factor receptor signaling pathway; and positive regulation of ERK1 and ERK2 cascade. Predicted to be located in plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

C18orf11; chromosome 18 open reading frame 11; FAM59A; family with sequence similarity 59, member A; GAREM; Gm944; GRB2 associated regulator of MAPK1 1; GRB2 associated, regulator of MAPK1; Grb2-associated and regulator of Erk/MAPK; GRB2-associated and regulator of MAPK protein; GRB2-associated and regulator of MAPK protein 1; GRB2-associated and regulator of MAPK1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	18	32,263,522 - 32,470,882 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	18	32,124,877 - 32,470,882 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	18	29,843,485 - 30,050,845 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	18	28,101,461 - 28,304,445 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	18	28,101,474 - 28,304,445	NCBI
Celera	18	26,654,417 - 26,857,408 (-)	NCBI		Celera
Cytogenetic Map	18	q12.1	NCBI
HuRef	18	26,700,077 - 26,907,135 (-)	NCBI		HuRef
CHM1_1	18	29,770,990 - 29,977,911 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	18	32,453,815 - 32,661,186 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	chromosome 18q deletion syndrome		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Monosomy 18q and deletion 18q	ClinVar	PMID:31690835
GAREM1	Human	intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	Garem1 (Mus musculus)	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GAREM1 mRNA	CTD	PMID:36331819
GAREM1	Human	1,2-dimethylhydrazine	decreases expression	ISO	Garem1 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in decreased expression of GAREM1 mRNA	CTD	PMID:22206623
GAREM1	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with TGFB1 protein] results in increased expression of GAREM1 mRNA	CTD	PMID:30165855
GAREM1	Human	17beta-estradiol	decreases expression	ISO	Garem1 (Mus musculus)	6480464	Estradiol results in decreased expression of GAREM1 mRNA	CTD	PMID:39298647
GAREM1	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Garem1 (Mus musculus)	6480464	Tetrachlorodibenzodioxin results in increased expression of GAREM1 mRNA	CTD	PMID:19933214
GAREM1	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	Garem1 (Mus musculus)	6480464	bisphenol S results in decreased expression of GAREM1 mRNA	CTD	PMID:39298647
GAREM1	Human	4-hydroxyphenyl retinamide	increases expression	ISO	Garem1 (Mus musculus)	6480464	Fenretinide results in increased expression of GAREM1 mRNA	CTD	PMID:28973697
GAREM1	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of GAREM1 protein	CTD	PMID:20106945
GAREM1	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of GAREM1 gene	CTD	PMID:27153756
GAREM1	Human	aflatoxin B1	decreases expression	EXP		6480464	Aflatoxin B1 results in decreased expression of GAREM1 mRNA	CTD	PMID:22100608
GAREM1	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of GAREM1 mRNA	CTD	PMID:21934132
GAREM1	Human	amphetamine	decreases expression	ISO	Garem1 (Rattus norvegicus)	6480464	Amphetamine results in decreased expression of GAREM1 mRNA	CTD	PMID:30779732
GAREM1	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of GAREM1 mRNA	CTD	PMID:33212167
GAREM1	Human	arsenite(3-)	decreases methylation	EXP		6480464	arsenite results in decreased methylation of GAREM1 promoter	CTD	PMID:23974009
GAREM1	Human	bisphenol A	increases expression	EXP		6480464	bisphenol A results in increased expression of GAREM1 mRNA	CTD	PMID:29275510
GAREM1	Human	bisphenol A	decreases expression	ISO	Garem1 (Mus musculus)	6480464	bisphenol A results in decreased expression of GAREM1 mRNA	CTD	PMID:38074096
GAREM1	Human	bisphenol A	increases expression	ISO	Garem1 (Mus musculus)	6480464	bisphenol A results in increased expression of GAREM1 mRNA	CTD	PMID:35598803
GAREM1	Human	bisphenol A	increases expression	ISO	Garem1 (Rattus norvegicus)	6480464	bisphenol A results in increased expression of GAREM1 mRNA	CTD	PMID:30816183
GAREM1	Human	bisphenol F	increases expression	ISO	Garem1 (Mus musculus)	6480464	bisphenol F results in increased expression of GAREM1 mRNA	CTD	PMID:38685157
GAREM1	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of GAREM1 mRNA	CTD	PMID:26472689
GAREM1	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of GAREM1 mRNA	CTD	PMID:38568856
GAREM1	Human	caffeine	increases phosphorylation	EXP		6480464	Caffeine results in increased phosphorylation of GAREM1 protein	CTD	PMID:35688186
GAREM1	Human	carbon nanotube	increases expression	ISO	Garem1 (Mus musculus)	6480464	Nanotubes more ...	CTD	PMID:25620056
GAREM1	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to GAREM1 gene]	CTD	PMID:28238834
GAREM1	Human	ciguatoxin CTX1B	affects expression	ISO	Garem1 (Mus musculus)	6480464	Ciguatoxins affects the expression of GAREM1 mRNA	CTD	PMID:18353800
GAREM1	Human	copper(II) sulfate	increases expression	EXP		6480464	Copper Sulfate results in increased expression of GAREM1 mRNA	CTD	PMID:19549813
GAREM1	Human	cyclosporin A	increases expression	EXP		6480464	Cyclosporine results in increased expression of GAREM1 mRNA	CTD	PMID:20106945 more ...
GAREM1	Human	DDE	decreases expression	EXP		6480464	Dichlorodiphenyl Dichloroethylene results in decreased expression of GAREM1 mRNA	CTD	PMID:38568856
GAREM1	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of GAREM1 mRNA	CTD	PMID:29803840
GAREM1	Human	fonofos	increases methylation	EXP		6480464	Fonofos results in increased methylation of GAREM1 promoter	CTD	PMID:22847954
GAREM1	Human	formaldehyde	decreases expression	EXP		6480464	Formaldehyde results in decreased expression of GAREM1 mRNA	CTD	PMID:23649840
GAREM1	Human	FR900359	decreases phosphorylation	EXP		6480464	FR900359 results in decreased phosphorylation of GAREM1 protein	CTD	PMID:37730182
GAREM1	Human	hydrogen peroxide	affects expression	EXP		6480464	Hydrogen Peroxide affects the expression of GAREM1 mRNA	CTD	PMID:20044591
GAREM1	Human	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		6480464	Arbutin results in increased expression of GAREM1 mRNA	CTD	PMID:17103032
GAREM1	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of GAREM1 mRNA	CTD	PMID:28903495
GAREM1	Human	leflunomide	increases expression	EXP		6480464	leflunomide results in increased expression of GAREM1 mRNA	CTD	PMID:28988120
GAREM1	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GAREM1 mRNA	CTD	PMID:35811015
GAREM1	Human	melphalan	decreases expression	EXP		6480464	Melphalan results in decreased expression of GAREM1 mRNA	CTD	PMID:22363485
GAREM1	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of GAREM1 mRNA	CTD	PMID:21420995 and PMID:22230336
GAREM1	Human	parathion	increases methylation	EXP		6480464	Parathion results in increased methylation of GAREM1 promoter	CTD	PMID:22847954
GAREM1	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	Garem1 (Mus musculus)	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GAREM1 mRNA	CTD	PMID:36331819
GAREM1	Human	quercetin	increases expression	EXP		6480464	Quercetin results in increased expression of GAREM1 mRNA	CTD	PMID:21632981
GAREM1	Human	rotenone	decreases expression	EXP		6480464	Rotenone results in decreased expression of GAREM1 mRNA	CTD	PMID:29955902
GAREM1	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GAREM1 mRNA	CTD	PMID:35811015
GAREM1	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of GAREM1 mRNA	CTD	PMID:25895662
GAREM1	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of GAREM1 mRNA	CTD	PMID:38568856
GAREM1	Human	sodium arsenite	decreases expression	ISO	Garem1 (Mus musculus)	6480464	sodium arsenite results in decreased expression of GAREM1 mRNA	CTD	PMID:37682722
GAREM1	Human	sunitinib	increases expression	EXP		6480464	Sunitinib results in increased expression of GAREM1 mRNA	CTD	PMID:31533062
GAREM1	Human	terbufos	increases methylation	EXP		6480464	terbufos results in increased methylation of GAREM1 promoter	CTD	PMID:22847954
GAREM1	Human	tetrachloromethane	increases expression	ISO	Garem1 (Rattus norvegicus)	6480464	Carbon Tetrachloride results in increased expression of GAREM1 mRNA	CTD	PMID:31150632
GAREM1	Human	thimerosal	decreases expression	EXP		6480464	Thimerosal results in decreased expression of GAREM1 mRNA	CTD	PMID:27188386
GAREM1	Human	titanium dioxide	increases methylation	ISO	Garem1 (Mus musculus)	6480464	titanium dioxide results in increased methylation of GAREM1 promoter	CTD	PMID:35295148
GAREM1	Human	titanium dioxide	decreases methylation	ISO	Garem1 (Mus musculus)	6480464	titanium dioxide results in decreased methylation of GAREM1 gene and titanium dioxide results in decreased methylation of GAREM1 promoter	CTD	PMID:35295148
GAREM1	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of GAREM1 mRNA	CTD	PMID:28818685
GAREM1	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of GAREM1 mRNA	CTD	PMID:25979313
GAREM1	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of GAREM1 mRNA	CTD	PMID:23179753
GAREM1	Human	vorinostat	decreases expression	EXP		6480464	vorinostat results in decreased expression of GAREM1 mRNA	CTD	PMID:27188386

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	cellular response to epidermal growth factor stimulus	involved_in	IDA		150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	cellular response to epidermal growth factor stimulus	involved_in	IBA	PANTHER:PTN002683723 and UniProtKB:Q9H706	150520179		GO_Central	GO_REF:0000033
GAREM1	Human	epidermal growth factor receptor signaling pathway	involved_in	IDA		150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	epidermal growth factor receptor signaling pathway	involved_in	IBA	PANTHER:PTN002683723 and UniProtKB:Q9H706	150520179		GO_Central	GO_REF:0000033
GAREM1	Human	multicellular organism growth	acts_upstream_of_or_within	IEA	UniProtKB:Q3UFT3 and ensembl:ENSMUSP00000048914	150520179		Ensembl	GO_REF:0000107
GAREM1	Human	positive regulation of cell division	involved_in	IEA	UniProtKB-KW:KW-0497	150520179		UniProt	GO_REF:0000043
GAREM1	Human	positive regulation of cell population proliferation	involved_in	IDA		150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	positive regulation of ERK1 and ERK2 cascade	involved_in	IMP		150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	positive regulation of ERK1 and ERK2 cascade	acts_upstream_of_or_within	IEA	UniProtKB:Q3UFT3 and ensembl:ENSMUSP00000048914	150520179		Ensembl	GO_REF:0000107

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	plasma membrane	located_in	NAS		150520179	PMID:19509291	UniProt	PMID:19509291

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	proline-rich region binding	enables	IDA		150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	proline-rich region binding	enables	IBA	PANTHER:PTN002683723 and UniProtKB:Q9H706	150520179		GO_Central	GO_REF:0000033
GAREM1	Human	protein binding	enables	IPI	UniProtKB:O75791 and UniProtKB:P62993	150520179	PMID:33961781	IntAct	PMID:33961781
GAREM1	Human	protein binding	enables	IPI	UniProtKB:O75791 and UniProtKB:P46108	150520179	PMID:25814554	IntAct	PMID:25814554
GAREM1	Human	protein binding	enables	IPI	UniProtKB:P00533 more ...	150520179	PMID:19509291	UniProt	PMID:19509291
GAREM1	Human	protein binding	enables	IPI	UniProtKB:O43639 more ...	150520179	PMID:32296183	IntAct	PMID:32296183
GAREM1	Human	protein binding	enables	IPI	UniProtKB:P62993	150520179	PMID:20936779 more ...	IntAct	PMID:20936779 more ...
GAREM1	Human	protein binding	enables	IPI	UniProtKB:P46108	150520179	PMID:35044719	IntAct	PMID:35044719

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GAREM1	Human	Intellectual disability		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar

#	Reference Title	Reference Citation
1.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
3.	Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.	Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.

PMID:14702039	PMID:15489334	PMID:15592455	PMID:15951569	PMID:18854154	PMID:19240061	PMID:19509291	PMID:20379614	PMID:20936779	PMID:21706016	PMID:21873635	PMID:21988832
PMID:24003223	PMID:25035420	PMID:25416956	PMID:25814554	PMID:25921289	PMID:26164232	PMID:26186194	PMID:26673895	PMID:28514442	PMID:29273731	PMID:30177387	PMID:31980649
PMID:32296183	PMID:32393512	PMID:33961781	PMID:34273398	PMID:35044719	PMID:35156780	PMID:35748872	PMID:36084556	PMID:37071682

GAREM1
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	18	32,263,522 - 32,470,882 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	18	32,124,877 - 32,470,882 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	18	29,843,485 - 30,050,845 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	18	28,101,461 - 28,304,445 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	18	28,101,474 - 28,304,445	NCBI
Celera	18	26,654,417 - 26,857,408 (-)	NCBI		Celera
Cytogenetic Map	18	q12.1	NCBI
HuRef	18	26,700,077 - 26,907,135 (-)	NCBI		HuRef
CHM1_1	18	29,770,990 - 29,977,911 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	18	32,453,815 - 32,661,186 (-)	NCBI		T2T-CHM13v2.0

Garem1
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	18	21,257,916 - 21,433,196 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	18	21,260,258 - 21,433,195 (-)	Ensembl		GRCm39 Ensembl
GRCm38	18	21,127,342 - 21,300,139 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	18	21,127,201 - 21,300,138 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	18	21,285,843 - 21,458,640 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	18	21,270,211 - 21,443,148 (-)	NCBI		MGSCv36	mm8
Celera	18	21,623,035 - 21,796,413 (-)	NCBI		Celera
Cytogenetic Map	18	A2	NCBI
cM Map	18	11.87	NCBI

Garem1
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	18	12,695,082 - 12,860,219 (-)	NCBI		GRCr8
mRatBN7.2	18	12,420,169 - 12,585,323 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	18	12,423,882 - 12,585,345 (-)	Ensembl		mRatBN7.2 Ensembl
Rnor_6.0	18	14,982,604 - 15,007,245 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	18	12,224,514 - 12,284,188 (-)	NCBI	Rnor6.0		rn6	Rnor6.0
Rnor_6.0 Ensembl	18	12,224,514 - 12,284,188 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	18	14,769,102 - 14,791,523 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	18	12,944,256 - 12,946,270 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	18	12,415,517 - 12,519,188 (-)	NCBI		Celera
Cytogenetic Map	18	p12	NCBI

Garem1
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955402	19,469,649 - 19,663,654 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955402	19,469,652 - 19,663,654 (-)	NCBI	ChiLan1.0	ChiLan1.0

GAREM1
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	17	49,639,460 - 49,847,521 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	18	35,332,057 - 35,540,119 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	18	25,470,702 - 25,678,146 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	18	29,065,053 - 29,272,225 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	18	29,065,053 - 29,272,231 (-)	Ensembl	panpan1.1		panPan2

GAREM1
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	7	57,158,005 - 57,423,643 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	7	57,295,070 - 57,419,252 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	7	56,654,442 - 56,856,713 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	7	57,196,399 - 57,404,576 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	7	57,195,979 - 57,400,589 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	7	56,881,075 - 57,082,118 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	7	56,898,894 - 57,100,606 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	7	57,195,790 - 57,397,330 (+)	NCBI		UU_Cfam_GSD_1.0

Garem1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404944	52,926,545 - 53,066,880 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936682	947,487 - 1,068,482 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936682	947,420 - 1,068,468 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

GAREM1
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	6	116,100,372 - 116,325,133 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	6	116,100,371 - 116,324,853 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	6	108,838,673 - 109,028,414 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

GAREM1
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	18	48,287,589 - 48,483,135 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	18	48,287,579 - 48,483,552 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666050	22,837,054 - 23,033,716 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Garem1
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624770	500,641 - 728,014 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624770	501,113 - 727,736 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in GAREM1
15 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 18q12.1-12.3(chr18:31655749-42564094)x3	copy number gain	See cases [RCV000050773]	Chr18:31655749..42564094 [GRCh38] Chr18:29235712..40144059 [GRCh37] Chr18:27489710..38398057 [NCBI36] Chr18:18q12.1-12.3	pathogenic
GRCh38/hg38 18q12.1-12.3(chr18:29444510-40403652)x1	copy number loss	See cases [RCV000051090]	Chr18:29444510..40403652 [GRCh38] Chr18:27024475..37983616 [GRCh37] Chr18:25278473..36237614 [NCBI36] Chr18:18q12.1-12.3	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:148963-80252149)x3	copy number gain	See cases [RCV000051048]	Chr18:148963..80252149 [GRCh38] Chr18:148963..78010032 [GRCh37] Chr18:138963..76111023 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q11.1-23(chr18:20960320-80234429)x3	copy number gain	See cases [RCV000052543]	Chr18:20960320..80234429 [GRCh38] Chr18:18540281..77992312 [GRCh37] Chr18:16794279..76093303 [NCBI36] Chr18:18q11.1-23	pathogenic
GRCh38/hg38 18q12.1-22.1(chr18:29249202-65448117)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052563]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052563]\|See cases [RCV000052563]	Chr18:29249202..65448117 [GRCh38] Chr18:26829167..63115353 [GRCh37] Chr18:25083165..61266333 [NCBI36] Chr18:18q12.1-22.1	pathogenic
GRCh38/hg38 18q12.1-12.3(chr18:32111530-44070219)x1	copy number loss	See cases [RCV000053829]	Chr18:32111530..44070219 [GRCh38] Chr18:29691493..41650184 [GRCh37] Chr18:27945491..39904182 [NCBI36] Chr18:18q12.1-12.3	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:53345-80209986)x3	copy number gain	See cases [RCV000052501]	Chr18:53345..80209986 [GRCh38] Chr18:53345..77967869 [GRCh37] Chr18:43345..76068860 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q11.1-23(chr18:20989762-80209986)x3	copy number gain	See cases [RCV000052549]	Chr18:20989762..80209986 [GRCh38] Chr18:18569723..77967869 [GRCh37] Chr18:16823721..76068860 [NCBI36] Chr18:18q11.1-23	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:148763-80252290)x3	copy number gain	See cases [RCV000052507]	Chr18:148763..80252290 [GRCh38] Chr18:148763..78010173 [GRCh37] Chr18:138763..76111164 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:148963-80244381)x3	copy number gain	See cases [RCV000052514]	Chr18:148963..80244381 [GRCh38] Chr18:148963..78002264 [GRCh37] Chr18:138963..76103255 [NCBI36] Chr18:18p11.32-q23	pathogenic
NM_001242409.1(GAREM):c.486C>T (p.Ile162=)	single nucleotide variant	Malignant melanoma [RCV000063360]	Chr18:32288111 [GRCh38] Chr18:29868074 [GRCh37] Chr18:28122072 [NCBI36] Chr18:18q12.1	not provided
GRCh38/hg38 18p11.32-q23(chr18:149089-80234391)x3	copy number gain	See cases [RCV000134110]	Chr18:149089..80234391 [GRCh38] Chr18:149089..77992274 [GRCh37] Chr18:139089..76093265 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q12.1(chr18:32462656-34463256)x1	copy number loss	See cases [RCV000141483]	Chr18:32462656..34463256 [GRCh38] Chr18:30042619..32043220 [GRCh37] Chr18:28296617..30297218 [NCBI36] Chr18:18q12.1	benign
GRCh38/hg38 18p11.32-q23(chr18:136227-80256240)x3	copy number gain	See cases [RCV000142244]	Chr18:136227..80256240 [GRCh38] Chr18:136227..78014123 [GRCh37] Chr18:126227..76115097 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q11.1-12.3(chr18:20941324-40360620)x3	copy number gain	See cases [RCV000142226]	Chr18:20941324..40360620 [GRCh38] Chr18:18521285..37940584 [GRCh37] Chr18:16775283..36194582 [NCBI36] Chr18:18q11.1-12.3	pathogenic
GRCh38/hg38 18q11.1-22.3(chr18:20962119-74691446)x3	copy number gain	See cases [RCV000143057]	Chr18:20962119..74691446 [GRCh38] Chr18:18542080..72403402 [GRCh37] Chr18:16796078..70532390 [NCBI36] Chr18:18q11.1-22.3	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:136226-80256240)x3	copy number gain	See cases [RCV000143218]	Chr18:136226..80256240 [GRCh38] Chr18:136226..78014123 [GRCh37] Chr18:126226..76115097 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q12.1-23(chr18:32123105-80252149)x3	copy number gain	See cases [RCV000136890]	Chr18:32123105..80252149 [GRCh38] Chr18:29703068..78010032 [GRCh37] Chr18:27957066..76111023 [NCBI36] Chr18:18q12.1-23	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:118760-80254946)x3	copy number gain	See cases [RCV000138656]	Chr18:118760..80254946 [GRCh38] Chr18:118760..78012829 [GRCh37] Chr18:108760..76113817 [NCBI36] Chr18:18p11.32-q23	pathogenic\|conflicting data from submitters
GRCh38/hg38 18p11.32-q23(chr18:149089-80254936)x3	copy number gain	See cases [RCV000139397]	Chr18:149089..80254936 [GRCh38] Chr18:149089..78012819 [GRCh37] Chr18:139089..76113807 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18q11.1-12.1(chr18:20949378-34363455)x3	copy number gain	See cases [RCV000141646]	Chr18:20949378..34363455 [GRCh38] Chr18:18529339..31943419 [GRCh37] Chr18:16783337..30197417 [NCBI36] Chr18:18q11.1-12.1	pathogenic
GRCh37/hg19 18q11.1-23(chr18:18548019-77954165)x3	copy number gain	See cases [RCV000240476]	Chr18:18548019..77954165 [GRCh37] Chr18:18q11.1-23	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:163323-78005185)x3	copy number gain	See cases [RCV000445851]	Chr18:163323..78005185 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18q11.2-12.2(chr18:20069932-36887326)x1	copy number loss	See cases [RCV000510691]	Chr18:20069932..36887326 [GRCh37] Chr18:18q11.2-12.2	pathogenic
GRCh37/hg19 18q11.1-22.1(chr18:18521285-64495798)x3	copy number gain	See cases [RCV000511734]	Chr18:18521285..64495798 [GRCh37] Chr18:18q11.1-22.1	pathogenic
GRCh37/hg19 18p11.21-q23(chr18:14869204-78014123)x3	copy number gain	See cases [RCV000512030]	Chr18:14869204..78014123 [GRCh37] Chr18:18p11.21-q23	pathogenic
GRCh37/hg19 18p11.32-q21.1(chr18:136227-46171053)x3	copy number gain	See cases [RCV000511857]	Chr18:136227..46171053 [GRCh37] Chr18:18p11.32-q21.1	pathogenic
GRCh37/hg19 18q11.2-21.1(chr18:24835114-46917217)x3	copy number gain	See cases [RCV000511124]	Chr18:24835114..46917217 [GRCh37] Chr18:18q11.2-21.1	likely benign
GRCh37/hg19 18p11.32-q23(chr18:136227-78014123)	copy number gain	See cases [RCV000511189]	Chr18:136227..78014123 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh38/hg38 18p11.32-q23(chr18:148963-80252149)x3	copy number gain	See cases [RCV000148072]	Chr18:148963..80252149 [GRCh38] Chr18:148963..78010032 [GRCh37] Chr18:138963..76111023 [NCBI36] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:163323-78005236)x3	copy number gain	See cases [RCV000240130]	Chr18:163323..78005236 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:136226-78014123)x3	copy number gain	See cases [RCV000446047]	Chr18:136226..78014123 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18q12.1-12.2(chr18:29711972-35866193)x1	copy number loss	not provided [RCV000684043]	Chr18:29711972..35866193 [GRCh37] Chr18:18q12.1-12.2	pathogenic
GRCh37/hg19 18q11.1-21.2(chr18:18539806-49926444)x2	copy number gain	not provided [RCV000739776]	Chr18:18539806..49926444 [GRCh37] Chr18:18q11.1-21.2	pathogenic
GRCh37/hg19 18q12.1(chr18:29885871-29889203)x1	copy number loss	not provided [RCV000739796]	Chr18:29885871..29889203 [GRCh37] Chr18:18q12.1	benign
GRCh37/hg19 18q12.1(chr18:29888503-29890042)x1	copy number loss	not provided [RCV000739797]	Chr18:29888503..29890042 [GRCh37] Chr18:18q12.1	benign
GRCh37/hg19 18p11.32-q23(chr18:12842-78015180)x3	copy number gain	not provided [RCV000752245]	Chr18:12842..78015180 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:13034-78015180)x3	copy number gain	not provided [RCV000752246]	Chr18:13034..78015180 [GRCh37] Chr18:18p11.32-q23	pathogenic
GRCh37/hg19 18q11.2-12.2(chr18:22868759-34335753)x1	copy number loss	not provided [RCV001006964]	Chr18:22868759..34335753 [GRCh37] Chr18:18q11.2-12.2	pathogenic
GRCh37/hg19 18q11.2-21.2(chr18:20689919-49455212)x3	copy number gain	not provided [RCV001006980]	Chr18:20689919..49455212 [GRCh37] Chr18:18q11.2-21.2	pathogenic
GRCh37/hg19 18q11.2-12.2(chr18:23971647-33737300)x1	copy number loss	See cases [RCV001263022]	Chr18:23971647..33737300 [GRCh37] Chr18:18q11.2-12.2	pathogenic
Single allele	deletion	Intellectual disability [RCV001787257]	Chr18:1262336..53254747 [GRCh37] Chr18:18p11.32-q21.2	pathogenic
GRCh37/hg19 18q11.2-23(chr18:23626739-78014976)x3	copy number gain	not provided [RCV001537911]	Chr18:23626739..78014976 [GRCh37] Chr18:18q11.2-23	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:136226-78014123)	copy number gain	not specified [RCV002052616]	Chr18:136226..78014123 [GRCh37] Chr18:18p11.32-q23	pathogenic
NM_001242409.2(GAREM1):c.2283T>A (p.Asp761Glu)	single nucleotide variant	not specified [RCV004111706]	Chr18:32268219 [GRCh38] Chr18:29848182 [GRCh37] Chr18:18q12.1	uncertain significance
NM_001242409.2(GAREM1):c.1129G>A (p.Asp377Asn)	single nucleotide variant	not specified [RCV004090633]	Chr18:32287468 [GRCh38] Chr18:29867431 [GRCh37] Chr18:18q12.1	uncertain significance
NM_001242409.2(GAREM1):c.839C>T (p.Thr280Met)	single nucleotide variant	not specified [RCV004094297]	Chr18:32287758 [GRCh38] Chr18:29867721 [GRCh37] Chr18:18q12.1	uncertain significance
GRCh37/hg19 18q12.1-12.3(chr18:26595964-38643072)x1	copy number loss	not provided [RCV003483335]	Chr18:26595964..38643072 [GRCh37] Chr18:18q12.1-12.3	pathogenic
GRCh37/hg19 18q12.1(chr18:29060989-30147476)x3	copy number gain	not provided [RCV004819637]	Chr18:29060989..30147476 [GRCh37] Chr18:18q12.1	uncertain significance
GRCh37/hg19 18q11.2-23(chr18:19309942-78014123)x3	copy number gain	not provided [RCV004819319]	Chr18:19309942..78014123 [GRCh37] Chr18:18q11.2-23	pathogenic
GRCh37/hg19 18q12.1(chr18:29943744-30863202)x3	copy number gain	not provided [RCV000684016]	Chr18:29943744..30863202 [GRCh37] Chr18:18q12.1	likely benign
Single allele	deletion	Deletion of long arm of chromosome 18 [RCV004801487]	Chr18:23614482..49306881 [GRCh38] Chr18:18q11.2-21.1	pathogenic
GRCh37/hg19 18p11.32-q23(chr18:1-78077248)	copy number gain	Trisomy 18 [RCV002280660]	Chr18:1..78077248 [GRCh37] Chr18:18p11.32-q23	pathogenic
NM_001242409.2(GAREM1):c.61G>T (p.Val21Leu)	single nucleotide variant	not specified [RCV004083219]	Chr18:32470368 [GRCh38] Chr18:30050331 [GRCh37] Chr18:18q12.1	uncertain significance
GRCh37/hg19 18q12.1(chr18:30003645-30241620)x3	copy number gain	not provided [RCV003485180]	Chr18:30003645..30241620 [GRCh37] Chr18:18q12.1	uncertain significance
NM_001242409.2(GAREM1):c.1886A>G (p.His629Arg)	single nucleotide variant	not specified [RCV004392712]	Chr18:32268616 [GRCh38] Chr18:29848579 [GRCh37] Chr18:18q12.1	uncertain significance
GRCh37/hg19 18q11.2-12.1(chr18:21553578-32172480)x1	copy number loss	not provided [RCV004819393]	Chr18:21553578..32172480 [GRCh37] Chr18:18q11.2-12.1	pathogenic

Predicted Target Of

	Summary Value
Count of predictions:	2110
Count of miRNA genes:	981
Interacting mature miRNAs:	1202
Transcripts:	ENST00000269209, ENST00000399218, ENST00000578619, ENST00000583696
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597606111	GWAS1662971_H	metabolic disease QTL GWAS1662971 (human)		4e-12	metabolic disease		18	32434326	32434327	Human
597024470	GWAS1120544_H	estrogen-receptor negative breast cancer QTL GWAS1120544 (human)		0.000005	estrogen-receptor negative breast cancer		18	32397726	32397727	Human
597049621	GWAS1145695_H	breast carcinoma QTL GWAS1145695 (human)		1e-11	mammary gland integrity trait (VT:0010552)		18	32397726	32397727	Human
407049792	GWAS698768_H	PR interval QTL GWAS698768 (human)		6e-08	PR interval	PR interval (CMO:0000233)	18	32452562	32452563	Human
597084528	GWAS1180602_H	PR interval QTL GWAS1180602 (human)		4e-14	PR interval	PR interval (CMO:0000233)	18	32440112	32440113	Human
597325459	GWAS1421533_H	forced expiratory volume QTL GWAS1421533 (human)		4e-10	forced expiratory volume	forced expiratory volume (CMO:0000254)	18	32387370	32387371	Human
597340820	GWAS1436894_H	lung adenocarcinoma QTL GWAS1436894 (human)		4e-08	lung adenocarcinoma		18	32342958	32342959	Human
407048147	GWAS697123_H	uric acid measurement QTL GWAS697123 (human)		0.000005	uric acid measurement	blood uric acid level (CMO:0000501)	18	32319104	32319105	Human
597086855	GWAS1182929_H	PR interval QTL GWAS1182929 (human)		0.000002	PR interval	PR interval (CMO:0000233)	18	32449178	32449179	Human
597079173	GWAS1175247_H	PR interval QTL GWAS1175247 (human)		2e-18	PR interval	PR interval (CMO:0000233)	18	32449178	32449179	Human
597113442	GWAS1209516_H	PR interval QTL GWAS1209516 (human)		0.000006	PR interval	PR interval (CMO:0000233)	18	32452562	32452563	Human
597350176	GWAS1446250_H	breast cancer QTL GWAS1446250 (human)		2e-11	breast cancer		18	32350613	32350614	Human
597023689	GWAS1119763_H	breast carcinoma QTL GWAS1119763 (human)		6e-12	mammary gland integrity trait (VT:0010552)		18	32397726	32397727	Human
597022344	GWAS1118418_H	TNF-related apoptosis-inducing ligand measurement QTL GWAS1118418 (human)		1e-08	TNF-related apoptosis-inducing ligand measurement		18	32304224	32304225	Human

D18S457

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,866,352 - 29,866,450	UniSTS	GRCh37
GRCh37	18	29,866,262 - 29,866,379	UniSTS	GRCh37
Build 36	18	28,120,260 - 28,120,377	RGD	NCBI36
Celera	18	26,673,215 - 26,673,332	RGD
Celera	18	26,673,305 - 26,673,403	UniSTS
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,722,948 - 26,723,046	UniSTS
HuRef	18	26,722,858 - 26,722,975	UniSTS
Marshfield Genetic Map	18	58.45	RGD
Genethon Genetic Map	18	58.9	UniSTS
TNG Radiation Hybrid Map	18	10779.0	UniSTS
deCODE Assembly Map	18	54.81	UniSTS
GeneMap99-GB4 RH Map	18	251.04	UniSTS
Whitehead-YAC Contig Map	18		UniSTS
GeneMap99-G3 RH Map	18	1066.0	UniSTS

WI-14403

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,847,661 - 29,847,790	UniSTS	GRCh37
Build 36	18	28,101,659 - 28,101,788	RGD	NCBI36
Celera	18	26,654,615 - 26,654,744	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,704,254 - 26,704,383	UniSTS
GeneMap99-GB4 RH Map	18	247.79	UniSTS
Whitehead-RH Map	18	247.7	UniSTS

D18S921E

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,847,774 - 29,847,955	UniSTS	GRCh37
Build 36	18	28,101,772 - 28,101,953	RGD	NCBI36
Celera	18	26,654,728 - 26,654,909	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,704,367 - 26,704,548	UniSTS

D18S937E

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,844,873 - 29,844,980	UniSTS	GRCh37
Build 36	18	28,098,871 - 28,098,978	RGD	NCBI36
Celera	18	26,651,827 - 26,651,934	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,701,466 - 26,701,573	UniSTS

SHGC-148085

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	30,031,299 - 30,031,576	UniSTS	GRCh37
Build 36	18	28,285,297 - 28,285,574	RGD	NCBI36
Celera	18	26,838,252 - 26,838,529	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,887,953 - 26,888,230	UniSTS
TNG Radiation Hybrid Map	18	10831.0	UniSTS

SHGC-153799

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	30,032,839 - 30,032,949	UniSTS	GRCh37
Build 36	18	28,286,837 - 28,286,947	RGD	NCBI36
Celera	18	26,839,792 - 26,839,902	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,889,493 - 26,889,603	UniSTS
TNG Radiation Hybrid Map	18	10831.0	UniSTS

G65665

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	30,001,670 - 30,001,933	UniSTS	GRCh37
Build 36	18	28,255,668 - 28,255,931	RGD	NCBI36
Celera	18	26,808,623 - 26,808,886	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,858,324 - 26,858,587	UniSTS

SHGC-36802

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,843,512 - 29,843,636	UniSTS	GRCh37
Build 36	18	28,097,510 - 28,097,634	RGD	NCBI36
Celera	18	26,650,466 - 26,650,590	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,700,105 - 26,700,229	UniSTS
Stanford-G3 RH Map	18	1066.0	UniSTS
GeneMap99-G3 RH Map	18	1066.0	UniSTS

SHGC-30861

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	30,001,668 - 30,001,803	UniSTS	GRCh37
Build 36	18	28,255,666 - 28,255,801	RGD	NCBI36
Celera	18	26,808,621 - 26,808,756	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,858,322 - 26,858,457	UniSTS
Stanford-G3 RH Map	18	1084.0	UniSTS
Whitehead-RH Map	18	268.7	UniSTS
NCBI RH Map	18	369.8	UniSTS
GeneMap99-G3 RH Map	18	1084.0	UniSTS

SHGC-52747

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	18	29,846,301 - 29,846,456	UniSTS	GRCh37
Build 36	18	28,100,299 - 28,100,454	RGD	NCBI36
Celera	18	26,653,255 - 26,653,410	RGD
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,702,894 - 26,703,049	UniSTS
TNG Radiation Hybrid Map	18	10770.0	UniSTS

WI-22103

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	18	q12.1	UniSTS
HuRef	18	26,727,676 - 26,727,751	UniSTS
Whitehead-RH Map	18	268.1	UniSTS

D18S457

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	18	q12.1	UniSTS
Marshfield Genetic Map	18	58.45	UniSTS
Genethon Genetic Map	18	58.9	UniSTS
TNG Radiation Hybrid Map	18	10776.0	UniSTS
deCODE Assembly Map	18	54.81	UniSTS
Whitehead-YAC Contig Map	18		UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2439	2788	2249	4971	1722	2346	6	624	1703	465	2269	7062	6228	50	3732	1	852	1744	1611	175	1


RefSeq Transcripts	NG_030329	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001242409	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_022751	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017025919	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024451234	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024451235	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_024451236	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047437739	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047437740	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054318978	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054318979	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054318980	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054318981	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC009835	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC015563	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC021224	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF086529	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AI479499	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK025263	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK025660	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK297430	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL834491	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC005074	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC121067	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC121068	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471088	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068260	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000269209 ⟹ ENSP00000269209

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	18	32,263,522 - 32,470,882 (-)	Ensembl

Ensembl Acc Id:

ENST00000399218 ⟹ ENSP00000382165

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	18	32,263,522 - 32,470,484 (-)	Ensembl

Ensembl Acc Id:

ENST00000578619

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	18	32,287,876 - 32,331,670 (-)	Ensembl

Ensembl Acc Id:

ENST00000583696 ⟹ ENSP00000464185

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	18	32,124,877 - 32,287,095 (-)	Ensembl

RefSeq Acc Id:

NM_001242409 ⟹ NP_001229338

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,263,522 - 32,470,882 (-)	NCBI
GRCh37	18	29,843,484 - 30,050,447 (-)	ENTREZGENE
HuRef	18	26,700,077 - 26,907,135 (-)	ENTREZGENE
CHM1_1	18	29,770,990 - 29,977,911 (-)	NCBI
T2T-CHM13v2.0	18	32,453,815 - 32,661,186 (-)	NCBI

Sequence:

show sequence

AGTCAGTGCTGGGAGCGCTGCTATGGCGTTTCTCAGACCCGCGGCTCCTCCTCACACGCTCGAGGCGGAGGGAAGGAGGGGTAAGAGGAGGAGGAGGCGAGCGGGCGGCCGCCGCAGCTGCAGACCCA
GGGCCAGAGGAGGAGGCGGAGCGGGAGCCGCCGCAGCCACCCGGGCCGCCGCCGCCGCCCGCAGCCGCGCGGCTGCTCTGAGTCTTCTCCGGGCGTGAGGGCACGCGGGGCGCCCCAGCCATGCCCCG
CAGCGGCAGCTGAGCCGGGCGCCGGCCCCCTCCCTCCGGGCCGCCCCAGTCGCCGCGCCCCCCCGGCTGCCCGCGGCCGGAGCTGCCCGGCGCCTCCCGCGCGCCCCAGACCGCGAGCGCGAGCAGCG
GCGGCCGCCGAGGCGCGGGTGGTGCCGGTGGCGGCGGCGGGGGAGCGCGGGACAGGAGGCTTCGGGGAAGATGGACCCGGCGCCCTCGCTGGGCTGCAGCCTCAAGGATGTGAAGTGGAGCTCGGTGG
CCGTGCCGCTCGACCTCCTGGTCAGCACTTACCGGCTGCCCCAGATCGCGCGCCTGGACAACGGAGAGTGCGTAGAAGGGCTGCGGGAAAATGACTATCTGCTGATTCATTCCTGCCGCCAGTGGACC
ACCATCACTGCCCACAGCTTGGAGGAGGGTCACTATGTCATTGGGCCAAAGATAGAGATTCCGGTACATTATGCAGGGCAATTCAAGCTGCTGGAACAAGACCGAGATATAAAGGAGCCAGTGCAATA
TTTCAACAGTGTGGAGGAGGTGGCTAAGGCATTTCCTGAACGCGTGTACGTCATGGAGGATATCACATTCAACGTGAAGGTTGCTTCAGGTGAATGCAATGAAGACACTGAAGTTTACAACATCACCC
TGTGTACTGGGGATGAACTCACTCTAATGGGGCAGGCAGAAATCCTTTATGCAAAGACATTCAAGGAAAAGTCACGACTCAACACAATCTTCAAAAAGATTGGGAAGCTCAATTCCATCAGCAAGCTG
GGAAAAGGCAAAATGCCGTGCCTCATTTGTATGAATCACCGGACCAACGAAAGCATTAGCCTTCCATTCCAGTGCAAGGGCAGATTTAGCACCCGAAGTCCCCTGGAACTTCAGATGCAAGAGGGCGA
ACACACCATCCGCAACATTGTGGAGAAAACCAGGCTTCCTGTGAATGTGACTGTGCCAAGCCCTCCACCGAGAAACCCATACGACCTCCACTTCATCCGTGAGGGGCACCGCTATAAGTTTGTGAACA
TCCAGACCAAGACGGTGGTGGTTTGCTGTGTGCTGCGGAACAACAAGATCCTCCCCATGCACTTTCCTTTGCACTTGACTGTCCCCAAGTTCAGCCTCCCAGAACACCTGGTGAAGGGAGAGAGCTGG
CCCGAAACCCTGGTCCATCACTGGCTAGGTATCTGCCAAGAACAGTTCGACATCGATGAGTATTCACGGGCTGTCCGTGATGTGAAAACCGACTGGAATGAAGAATGCAAGAGCCCCAAGAAGGGTCG
GTGCTCTGGCCACAACCACGTGCCCAATTCGCTCAGCTACGCCCGCGATGAGCTCACCCAGTCCTTCCACCGACTCTCGGTCTGTGTGTATGGCAACAATCTCCATGGCAACAGTGAGGTGAACCTTC
ATGGTTGCAGGGACCTGGGGGGAGATTGGGCTCCCTTTCCTCATGACATCCTGCCCTATCAGGACTCTGGAGATAGTGGGAGCGACTACCTTTTCCCAGAAGCTAGTGAAGAATCAGCAGGCATCCCG
GGAAAGTCAGAACTTCCCTACGAAGAGCTGTGGCTGGAGGAAGGCAAGCCCAGCCATCAGCCTCTCACTCGCTCTCTGAGCGAGAAGAACAGATGTGATCAGTTTAGAGGTTCTGTCCGATCCAAATG
TGCGACTTCTCCTCTTCCCATCCCTGGGACTCTGGGAGCAGCAGTGAAGTCTTCAGATACTGCCCTACCTCCACCTCCAGTGCCTCCCAAATCTGAAGCCGTCAGAGAAGAATGCCGGCTCCTGAACG
CCCCACCTGTTCCACCCCGAAGCGCAAAGCCTTTGTCCACCAGTCCCTCCATCCCTCCTCGCACAGTCAAGCCAGCGCGGCAACAGACTCGCTCTCCCAGCCCCACCTTGTCCTACTATTCTTCAGGG
CTACACAACATCAGCGTCACTAAAACTGACACAAATCCTTCTGAAAGCACTCCTGTTTCCTGCTATCCATGTAACCGAGTGAAAACTGATTCTGTGGACCTGAAATCCCCGTTTGGAAGTCCTTCTGC
TGAAGCTGTGTCCTCTCGGCTCTCATGGCCTAACCATTATTCAGGAGCATCAGAAAGCCAGACCAGGAGTGACTTCCTGCTGGATCCAAGCAGGAGTTATAGTTACCCTAGACAAAAGACGCCAGGCA
CACCAAAGAGAAACTGCCCAGCACCTTTTGATTTTGATGGCTGTGAGCTCCTGGCCAGCCCCACTAGCCCAGTCACTGCAGAATTCAGTAGCAGCGTCTCTGGTTGTCCCAAGTCAGCCAGCTACTCT
CTGGAGAGCACAGATGTGAAATCTCTTGCAGCTGGTGTGACAAAGCAGAGTACGTCATGCCCTGCCTTACCCCCCAGGGCTCCAAAACTAGTGGAAGAGAAGGTCGCCTCCGAAACATCTCCTTTGCC
TCTGAAAATTGATGGTGCTGAGGAAGACCCCAAGTCTGGGTCACCAGATCTCTCGGAGGACCAGTATTTTGTTAAAAAGGGCATGCAGGACATCTTCTCTGCCTCCTACCCTTTCTCATCTCCGCTCC
ATCTCCAGCTGGCCCCCAGATCCTGTGGCGACGGTTCCCCATGGCAGCCACCTGCTGACCTATCAGGACTCTCTATAGAGGAAGTGTCCAAGTCACTACGGTTCATTGGTTTGTCCGAAGATGTCATA
TCATTCTTTGTTACTGAAAAGATTGATGGGAACCTGCTTGTTCAGCTAACGGAAGAAATCCTCTCAGAGGATTTCAAATTGAGCAAATTGCAGGTGAAGAAGATAATGCAATTCATTAATGGCTGGAG
GCCCAAAATATAGCCAAATAACCCCCGGCCAGCATGGAACAAAACTGATCAATGCGTGTGCTAGAAGGGGTGGGCTGGGACACAATTTCATGTTTTTGCACTAAAAACCTTCTCTGTAAATAGGGATA
AGAGAAACTCTTACTATGCAGATTACGTTTTTGAATGGTGAACAGGCTATTTTGTACATCAATAAAAATGCTGTACAGAACACTTGGAGGTGTGCCTTGTACGTCACTCAACAAACACTCAGCAGCTG
CTAAAAGAAAAAAAGGCATGTGCAGAGAAATCATTCTTACCCAAGTAGGTTTATGTGAGAAGGTATGATATTTATTACAAAATAGCCAAAGCTGGAAGACATAAAAATCTTTAAAAAAAAAAAAAAAA
CACTTTTGAACAAGTCCCTTCTTTCAGGAGGGTTGACTTTAGACAATTAACTGTGTTCTGTGCTCTGTCATTCAGATTGCTTCTTGCTAATTGTTTTACTCTTGTGCCTGAAAATGTTAGTGATACGA
ATTGACACTTTAATGTTGTATGCTTGGTGGGGATCTTTTTATCACAAGGCATTTTCCAAGAGTCATATGTTGATAAAGGGATATATGTTGTCCTTAGAAATCACACAAATCATGACCACAATAATTTA
TCTGTAACTGCTGCTAATTTTATTGAGCAGAGAAAAAAGAATATACATATATAAACATGTATAGGTGCATACACAATACACCCGGATATGTTTTACACATAATTTTGATTCTGATATTTTAGATAACA
TCTGTTCACTTTTAAACAATCTGTTGAGGTTTTGGGACTGTTATCTACATTGATTCTCTTAGGAATAGTGGACAGAATGACTCCAAAGATTCTCAGAACCCTGTCTCTTGAAGCTCAATCTTATTTGG
GTTCATCACTGAAAACTTAGAACAAATCAGTAAAGAATCCTGTATTGAAGAATTAAGTTTGAGTTTAAGCCCACTCACCGCAGGGCTGGTTTTTGCATGTAATACTCCCATGATGTCTGGGGAAATGA
CAGTTTCTGTTGAATTATAATTCTCCGGTTTAAGGGTCTCCTTCCCCTGGTGTCTGATGGTGAGAGGTCTGAAGAGCATTTGTCAGAGTACATTAGGCATTCTCAACCTACTTCATGCTTTACGAGAG
CTGAGAAATCAGACGCACCGGCCTTTATTATTATATATGCTACATCTGTTGAGTATTTTTAAAATACCAATAAGAGGACTTGTTTATTTCATAAACCACTTCTTCCCTCTCTTTCAAAGAAAATACAT
TATTACCATACTTTTACATTAGTCTGAGAATTTTTGCTAAATATGATTAAGTATTCCAAAATATAATGGCGTCATTATTCTTGACTTTTTTAGAGAATATACATCTTAAGACTGTATTAGTTCTCAGA
GCAAGGCATCATCTACTCCCCTGCACCTGAGAGTCTGGCCCCAGATTCCAGATGTGCGGACAGCCCATGACCGAGGTGCACACAGTGCCCTCTTGAATAGGAAGGTCAGCCAGTGAGGCGGCAGCATA
ACTTGCAGGATGGACTTATATCTTACCATCTCTTCCTGCTACCAAAATAAAAAAATAAATTGAAAGACAAGACCCACCAGTCTAGTTTTGTAGACCTGTGAAATGTGTCTTTATTTCTTGGCATTAGA
AGAAAGATATTTTTAATCCATATCGTGGTTTTAGAGTTGAAGTGAATTGATACCCAATTTTCCATCTTAGATCTCCTTTATCAAAAAAAAAAGCATTTTTTTTCTCCTAACGTGTCTCCCAAAATGTA
AATACTATAGGCAAAAAGAGTACCCTGTAAAATTCTCACACTGGAGCACCTCTTCAAAAGTCACAGATAACTCAATGAGGAAGTGCTGGTACTGCACTCACAGGACATGAGACCTATGAAGCTTTCGT
GTTTTGAAAGCATCCTTCTGTGTGAGGGGGACTGCCTCCCTTAGTAAAGTAAACCTCTCAGAACTTCTTTTTAAAATAAAAACAGACAAGATGCAGTTACTAAGCTGCAAGTTTTCATTGGCAAACCT
AGCTGAATCCGTTTTAAAATACTTAGCACTCGGACACAATTCTCAAACTCAGGAAGAAGGAACAGGGTTGGTTTGGGTTTACTATAAAGGTTGCCTCACATAAACAACTGACTCCTTTTAGCGTTTTT
TTTCTTTTTGTAAAAACTTTACACAAAATAGGGTTTTAAATTCTTTTTGCTTGTTTTGGACTTGGTGTATTTTTGTCAAGTTTATATTGATTGGCAACGCAGAGACTCCTTGAGGGCAGGGACTGTGG
CCTTTGATTCACTTATGCTACAGTCTAGTATCACTACAGTGCTGAGTAAAAGACACAGCCCCTGCCCTCTTGGAGATCATATTGTTTATATTTGAAATCTCAGTTGCTAAGAGTATGTATGTGTGAGT
AAGAAAGACGTGAAGTCCTATGGGCAGCTGGGTATATGGAGAATTACGTGTGTCCTGTCTTTAAAACGTCAGCCTCTATTAAGGGGTACAGAACACCCCAAGATCACTAAAACTTGGAATGTGTTGGA
GGCAGAAAGTATCTCTCTCATTGCCTAGTGTTGTTGTTTTTTTGTTTTTTGTTTTTTGTTTTTTTTACTGACCTGGAATTCTTTTAATTGTAATAAATATCTTCTGTCACAAATAAATGCCACAAATA
AATGAAATTGCCATTCCTAAGCTGAGCACCTGTCTGTGAAGGACCTTGGTGTCCTGACTGGACAGAGCATTCATAGCTCCAAGAGAATCATGACAAGATATGCAAAGCAGGGATAATAAGGAGAAAGC
CCTTCCCTTTCGAGAAGCCCTTCCCTTTCACAGCCCTTCCCTGCGATTCTGCAGTGAAAAGTGATGCCCAGAGATCCACACACAGAACCCTTCTAACCAGCCAGGTCAAGACTTATCATCTTATCTCC
TCTGGCAGGTCCCCTGTAATCAAAAGAGAGGAAGTGTCTATCTAAACAAGACCCTTTTGGGTCCTTAGATTCATGGCAAAAATCATCATGGCCCCCATCAGAAAAGAAAATCAGCAATAAACCAAGCC
AAGCAACTAAAATGTATAATGTGGACCTGACTCATGTTGGGAGGCAGAATTCAGACACTCACAGATCAATCTTGCAAGTTTTCTCTTCTTTAAGTTGAGCTGCTCAACTTTATGAACTGTGAAATTTA
CTTACATTCTTTCAACCCACATATATCATTGCAGTTTATGAAGTTGCAGTGAACTGCCCATTCAGCTAAATTGCAGTGTTTATTCTTGTCTCATGTCGAAATACAACAATCTTATGGGAAATATTATG
ACAGTCCGTTCCAACTGTTCTCAGACACATGCATAAACAGTCTCTGCTCACATTCCACAGCCACCTGCATGTTATCCATACAGCTCCCTGAGAAGTCCAGGGATGGGAGGTGGGGTGTGGAAGGATGG
AGGGTCCTTCATTTTCTAAACACTTTGTATAAGTCACTACTCATCGTGCCTAGCAAGTATAAGATTAACATTTTGAATAACAAACTGGAAAACAAATAATCCTTCAAAGAACCTAGCGAACTGTTCAA
AGGAAATTTTAATTTCAGTCTACCAGAAAAGTTAAATCTGTTGTTGGACGTAGGGGGCTTTCAGAAACATGCCTCTTATATCAATTTCCACTATCTTTCAAGTTACCTAAAGGCACCAGGCTGCTTGA
GCAAGAAGAATAAAAGGCCTAGAGTGCAAATTATGTGAAGTAGAGTTTTTAGATTGTGGGATTGTAATAATACGGGATTCTCATGGTTACATCATGTTAAATCACACTGTTCAGTCTTTAAAACTTGG
TGTTTTAAAATTTGTCTCATTGTGATAGCCAGAAACAAGGAATAAACGTGATTTCAGTTTAAACTATATACAAATATCTTCTGTAATTTTGCTGCTCTAATTTTTAGGCTATAAATTTTGTAATAGAG
CTTATCAGATCGCAAATTTCCTTTGTTTACAATCTCATGTAGTAGGGCTCAGATAATTTCTTAGCTATAAACCTTTTCTCCCACTCTCATATTGTTTCATTTAAAATATTTAAGCTAAGCCTAAAAAT
TGAAATCAGTTAAGAATTTGGAGAGTTTATCTTAAATGGAAATGGTGTATTCTTTTCAAAGAATTTTGTAACCATCTTTACAGTTTCTTTGCTTGGAAAACTTGGGTTGTTAACTACCAGTTAACAAT
GGCATTACTTTCCAAAACGTTATCTAATGGGCCCAATGTGTACCTCAAGATAAACACAGTATGTTATGTCTAAAAATTTCCTTGTCTGTTGATTTAAATGGTTCTGAAATGTCTGTAATAAAGAAATT
TTCAAAGTTG

hide sequence

RefSeq Acc Id:

NM_022751 ⟹ NP_073588

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,263,522 - 32,470,882 (-)	NCBI
GRCh37	18	29,843,484 - 30,050,447 (-)	NCBI
Build 36	18	28,101,461 - 28,304,445 (-)	NCBI Archive
Celera	18	26,654,417 - 26,857,408 (-)	RGD
HuRef	18	26,700,077 - 26,907,135 (-)	ENTREZGENE
CHM1_1	18	29,770,990 - 29,977,911 (-)	NCBI
T2T-CHM13v2.0	18	32,453,815 - 32,661,186 (-)	NCBI

Sequence:

show sequence

AGTCAGTGCTGGGAGCGCTGCTATGGCGTTTCTCAGACCCGCGGCTCCTCCTCACACGCTCGAG
GCGGAGGGAAGGAGGGGTAAGAGGAGGAGGAGGCGAGCGGGCGGCCGCCGCAGCTGCAGACCCAGGGCCAGAGGAGGAGGCGGAGCGGGAGCCGCCGCAGCCACCCGGGCCGCCGCCGCCGCCCGCAG
CCGCGCGGCTGCTCTGAGTCTTCTCCGGGCGTGAGGGCACGCGGGGCGCCCCAGCCATGCCCCGCAGCGGCAGCTGAGCCGGGCGCCGGCCCCCTCCCTCCGGGCCGCCCCAGTCGCCGCGCCCCCCC
GGCTGCCCGCGGCCGGAGCTGCCCGGCGCCTCCCGCGCGCCCCAGACCGCGAGCGCGAGCAGCGGCGGCCGCCGAGGCGCGGGTGGTGCCGGTGGCGGCGGCGGGGGAGCGCGGGACAGGAGGCTTCG
GGGAAGATGGACCCGGCGCCCTCGCTGGGCTGCAGCCTCAAGGATGTGAAGTGGAGCTCGGTGGCCGTGCCGCTCGACCTCCTGGTCAGCACTTACCGGCTGCCCCAGATCGCGCGCCTGGACAACGG
AGAGTGCGTAGAAGGGCTGCGGGAAAATGACTATCTGCTGATTCATTCCTGCCGCCAGTGGACCACCATCACTGCCCACAGCTTGGAGGAGGGTCACTATGTCATTGGGCCAAAGATAGAGATTCCGG
TACATTATGCAGGGCAATTCAAGCTGCTGGAACAAGACCGAGATATAAAGGAGCCAGTGCAATATTTCAACAGTGTGGAGGAGGTGGCTAAGGCATTTCCTGAACGCGTGTACGTCATGGAGGATATC
ACATTCAACGTGAAGGTTGCTTCAGGTGAATGCAATGAAGACACTGAAGTTTACAACATCACCCTGTGTACTGGGGATGAACTCACTCTAATGGGGCAGGCAGAAATCCTTTATGCAAAGACATTCAA
GGAAAAGTCACGACTCAACACAATCTTCAAAAAGATTGGGAAGCTCAATTCCATCAGCAAGCTGGGAAAAGGCAAAATGCCGTGCCTCATTTGTATGAATCACCGGACCAACGAAAGCATTAGCCTTC
CATTCCAGTGCAAGGGCAGATTTAGCACCCGAAGTCCCCTGGAACTTCAGATGCAAGAGGGCGAACACACCATCCGCAACATTGTGGAGAAAACCAGGCTTCCTGTGAATGTGACTGTGCCAAGCCCT
CCACCGAGAAACCCATACGACCTCCACTTCATCCGTGAGGGGCACCGCTATAAGTTTGTGAACATCCAGACCAAGACGGTGGTGGTTTGCTGTGTGCTGCGGAACAACAAGATCCTCCCCATGCACTT
TCCTTTGCACTTGACTGTCCCCAAGTTCAGCCTCCCAGAACACCTGGTGAAGGGAGAGAGCTGGCCCGAAACCCTGGTCCATCACTGGCTAGGTATCTGCCAAGAACAGTTCGACATCGATGAGTATT
CACGGGCTGTCCGTGATGTGAAAACCGACTGGAATGAAGAATGCAAGAGCCCCAAGAAGGGTCGGTGCTCTGGCCACAACCACGTGCCCAATTCGCTCAGCTACGCCCGCGATGAGCTCACCCAGTCC
TTCCACCGACTCTCGGTCTGTGTGTATGGCAACAATCTCCATGGCAACAGTGAGGTGAACCTTCATGGTTGCAGGGACCTGGGGGGAGATTGGGCTCCCTTTCCTCATGACATCCTGCCCTATCAGGA
CTCTGGAGATAGTGGGAGCGACTACCTTTTCCCAGAAGCTAGTGAAGAATCAGCAGGCATCCCGGGAAAGTCAGAACTTCCCTACGAAGAGCTGTGGCTGGAGGAAGGCAAGCCCAGCCATCAGCCTC
TCACTCGCTCTCTGAGCGAGAAGAACAGATGTGATCAGTTTAGAGGTTCTGTCCGATCCAAATGTGCGACTTCTCCTCTTCCCATCCCTGGGACTCTGGGAGCAGCAGTGAAGTCTTCAGATACTGCC
CTACCTCCACCTCCAGTGCCTCCCAAATCTGAAGCCGTCAGAGAAGAATGCCGGCTCCTGAACGCCCCACCTGTTCCACCCCGAAGCGCAAAGCCTTTGTCCACCAGTCCCTCCATCCCTCCTCGCAC
AGTCAAGCCAGCGCGGCAACAGACTCGCTCTCCCAGCCCCACCTTGTCCTACTATTCTTCAGGGCTACACAACATCGTCACTAAAACTGACACAAATCCTTCTGAAAGCACTCCTGTTTCCTGCTATC
CATGTAACCGAGTGAAAACTGATTCTGTGGACCTGAAATCCCCGTTTGGAAGTCCTTCTGCTGAAGCTGTGTCCTCTCGGCTCTCATGGCCTAACCATTATTCAGGAGCATCAGAAAGCCAGACCAGG
AGTGACTTCCTGCTGGATCCAAGCAGGAGTTATAGTTACCCTAGACAAAAGACGCCAGGCACACCAAAGAGAAACTGCCCAGCACCTTTTGATTTTGATGGCTGTGAGCTCCTGGCCAGCCCCACTAG
CCCAGTCACTGCAGAATTCAGTAGCAGCGTCTCTGGTTGTCCCAAGTCAGCCAGCTACTCTCTGGAGAGCACAGATGTGAAATCTCTTGCAGCTGGTGTGACAAAGCAGAGTACGTCATGCCCTGCCT
TACCCCCCAGGGCTCCAAAACTAGTGGAAGAGAAGGTCGCCTCCGAAACATCTCCTTTGCCTCTGAAAATTGATGGTGCTGAGGAAGACCCCAAGTCTGGGTCACCAGATCTCTCGGAGGACCAGTAT
TTTGTTAAAAAGGGCATGCAGGACATCTTCTCTGCCTCCTACCCTTTCTCATCTCCGCTCCATCTCCAGCTGGCCCCCAGATCCTGTGGCGACGGTTCCCCATGGCAGCCACCTGCTGACCTATCAGG
ACTCTCTATAGAGGAAGTGTCCAAGTCACTACGGTTCATTGGTTTGTCCGAAGATGTCATATCATTCTTTGTTACTGAAAAGATTGATGGGAACCTGCTTGTTCAGCTAACGGAAGAAATCCTCTCAG
AGGATTTCAAATTGAGCAAATTGCAGGTGAAGAAGATAATGCAATTCATTAATGGCTGGAGGCCCAAAATATAGCCAAATAACCCCCGGCCAGCATGGAACAAAACTGATCAATGCGTGTGCTAGAAG
GGGTGGGCTGGGACACAATTTCATGTTTTTGCACTAAAAACCTTCTCTGTAAATAGGGATAAGAGAAACTCTTACTATGCAGATTACGTTTTTGAATGGTGAACAGGCTATTTTGTACATCAATAAAA
ATGCTGTACAGAACACTTGGAGGTGTGCCTTGTACGTCACTCAACAAACACTCAGCAGCTGCTAAAAGAAAAAAAGGCATGTGCAGAGAAATCATTCTTACCCAAGTAGGTTTATGTGAGAAGGTATG
ATATTTATTACAAAATAGCCAAAGCTGGAAGACATAAAAATCTTTAAAAAAAAAAAAAAAACACTTTTGAACAAGTCCCTTCTTTCAGGAGGGTTGACTTTAGACAATTAACTGTGTTCTGTGCTCTG
TCATTCAGATTGCTTCTTGCTAATTGTTTTACTCTTGTGCCTGAAAATGTTAGTGATACGAATTGACACTTTAATGTTGTATGCTTGGTGGGGATCTTTTTATCACAAGGCATTTTCCAAGAGTCATA
TGTTGATAAAGGGATATATGTTGTCCTTAGAAATCACACAAATCATGACCACAATAATTTATCTGTAACTGCTGCTAATTTTATTGAGCAGAGAAAAAAGAATATACATATATAAACATGTATAGGTG
CATACACAATACACCCGGATATGTTTTACACATAATTTTGATTCTGATATTTTAGATAACATCTGTTCACTTTTAAACAATCTGTTGAGGTTTTGGGACTGTTATCTACATTGATTCTCTTAGGAATA
GTGGACAGAATGACTCCAAAGATTCTCAGAACCCTGTCTCTTGAAGCTCAATCTTATTTGGGTTCATCACTGAAAACTTAGAACAAATCAGTAAAGAATCCTGTATTGAAGAATTAAGTTTGAGTTTA
AGCCCACTCACCGCAGGGCTGGTTTTTGCATGTAATACTCCCATGATGTCTGGGGAAATGACAGTTTCTGTTGAATTATAATTCTCCGGTTTAAGGGTCTCCTTCCCCTGGTGTCTGATGGTGAGAGG
TCTGAAGAGCATTTGTCAGAGTACATTAGGCATTCTCAACCTACTTCATGCTTTACGAGAGCTGAGAAATCAGACGCACCGGCCTTTATTATTATATATGCTACATCTGTTGAGTATTTTTAAAATAC
CAATAAGAGGACTTGTTTATTTCATAAACCACTTCTTCCCTCTCTTTCAAAGAAAATACATTATTACCATACTTTTACATTAGTCTGAGAATTTTTGCTAAATATGATTAAGTATTCCAAAATATAAT
GGCGTCATTATTCTTGACTTTTTTAGAGAATATACATCTTAAGACTGTATTAGTTCTCAGAGCAAGGCATCATCTACTCCCCTGCACCTGAGAGTCTGGCCCCAGATTCCAGATGTGCGGACAGCCCA
TGACCGAGGTGCACACAGTGCCCTCTTGAATAGGAAGGTCAGCCAGTGAGGCGGCAGCATAACTTGCAGGATGGACTTATATCTTACCATCTCTTCCTGCTACCAAAATAAAAAAATAAATTGAAAGA
CAAGACCCACCAGTCTAGTTTTGTAGACCTGTGAAATGTGTCTTTATTTCTTGGCATTAGAAGAAAGATATTTTTAATCCATATCGTGGTTTTAGAGTTGAAGTGAATTGATACCCAATTTTCCATCT
TAGATCTCCTTTATCAAAAAAAAAAGCATTTTTTTTCTCCTAACGTGTCTCCCAAAATGTAAATACTATAGGCAAAAAGAGTACCCTGTAAAATTCTCACACTGGAGCACCTCTTCAAAAGTCACAGA
TAACTCAATGAGGAAGTGCTGGTACTGCACTCACAGGACATGAGACCTATGAAGCTTTCGTGTTTTGAAAGCATCCTTCTGTGTGAGGGGGACTGCCTCCCTTAGTAAAGTAAACCTCTCAGAACTTC
TTTTTAAAATAAAAACAGACAAGATGCAGTTACTAAGCTGCAAGTTTTCATTGGCAAACCTAGCTGAATCCGTTTTAAAATACTTAGCACTCGGACACAATTCTCAAACTCAGGAAGAAGGAACAGGG
TTGGTTTGGGTTTACTATAAAGGTTGCCTCACATAAACAACTGACTCCTTTTAGCGTTTTTTTTCTTTTTGTAAAAACTTTACACAAAATAGGGTTTTAAATTCTTTTTGCTTGTTTTGGACTTGGTG
TATTTTTGTCAAGTTTATATTGATTGGCAACGCAGAGACTCCTTGAGGGCAGGGACTGTGGCCTTTGATTCACTTATGCTACAGTCTAGTATCACTACAGTGCTGAGTAAAAGACACAGCCCCTGCCC
TCTTGGAGATCATATTGTTTATATTTGAAATCTCAGTTGCTAAGAGTATGTATGTGTGAGTAAGAAAGACGTGAAGTCCTATGGGCAGCTGGGTATATGGAGAATTACGTGTGTCCTGTCTTTAAAAC
GTCAGCCTCTATTAAGGGGTACAGAACACCCCAAGATCACTAAAACTTGGAATGTGTTGGAGGCAGAAAGTATCTCTCTCATTGCCTAGTGTTGTTGTTTTTTTGTTTTTTGTTTTTTGTTTTTTTTA
CTGACCTGGAATTCTTTTAATTGTAATAAATATCTTCTGTCACAAATAAATGCCACAAATAAATGAAATTGCCATTCCTAAGCTGAGCACCTGTCTGTGAAGGACCTTGGTGTCCTGACTGGACAGAG
CATTCATAGCTCCAAGAGAATCATGACAAGATATGCAAAGCAGGGATAATAAGGAGAAAGCCCTTCCCTTTCGAGAAGCCCTTCCCTTTCACAGCCCTTCCCTGCGATTCTGCAGTGAAAAGTGATGC
CCAGAGATCCACACACAGAACCCTTCTAACCAGCCAGGTCAAGACTTATCATCTTATCTCCTCTGGCAGGTCCCCTGTAATCAAAAGAGAGGAAGTGTCTATCTAAACAAGACCCTTTTGGGTCCTTA
GATTCATGGCAAAAATCATCATGGCCCCCATCAGAAAAGAAAATCAGCAATAAACCAAGCCAAGCAACTAAAATGTATAATGTGGACCTGACTCATGTTGGGAGGCAGAATTCAGACACTCACAGATC
AATCTTGCAAGTTTTCTCTTCTTTAAGTTGAGCTGCTCAACTTTATGAACTGTGAAATTTACTTACATTCTTTCAACCCACATATATCATTGCAGTTTATGAAGTTGCAGTGAACTGCCCATTCAGCT
AAATTGCAGTGTTTATTCTTGTCTCATGTCGAAATACAACAATCTTATGGGAAATATTATGACAGTCCGTTCCAACTGTTCTCAGACACATGCATAAACAGTCTCTGCTCACATTCCACAGCCACCTG
CATGTTATCCATACAGCTCCCTGAGAAGTCCAGGGATGGGAGGTGGGGTGTGGAAGGATGGAGGGTCCTTCATTTTCTAAACACTTTGTATAAGTCACTACTCATCGTGCCTAGCAAGTATAAGATTA
ACATTTTGAATAACAAACTGGAAAACAAATAATCCTTCAAAGAACCTAGCGAACTGTTCAAAGGAAATTTTAATTTCAGTCTACCAGAAAAGTTAAATCTGTTGTTGGACGTAGGGGGCTTTCAGAAA
CATGCCTCTTATATCAATTTCCACTATCTTTCAAGTTACCTAAAGGCACCAGGCTGCTTGAGCAAGAAGAATAAAAGGCCTAGAGTGCAAATTATGTGAAGTAGAGTTTTTAGATTGTGGGATTGTAA
TAATACGGGATTCTCATGGTTACATCATGTTAAATCACACTGTTCAGTCTTTAAAACTTGGTGTTTTAAAATTTGTCTCATTGTGATAGCCAGAAACAAGGAATAAACGTGATTTCAGTTTAAACTAT
ATACAAATATCTTCTGTAATTTTGCTGCTCTAATTTTTAGGCTATAAATTTTGTAATAGAGCTTATCAGATCGCAAATTTCCTTTGTTTACAATCTCATGTAGTAGGGCTCAGATAATTTCTTAGCTA
TAAACCTTTTCTCCCACTCTCATATTGTTTCATTTAAAATATTTAAGCTAAGCCTAAAAATTGAAATCAGTTAAGAATTTGGAGAGTTTATCTTAAATGGAAATGGTGTATTCTTTTCAAAGAATTTT
GTAACCATCTTTACAGTTTCTTTGCTTGGAAAACTTGGGTTGTTAACTACCAGTTAACAATGGCATTACTTTCCAAAACGTTATCTAATGGGCCCAATGTGTACCTCAAGATAAACACAGTATGTTAT
GTCTAAAAATTTCCTTGTCTGTTGATTTAAATGGTTCTGAAATGTCTGTAATAAAGAAATTTTCAAAGTTG

hide sequence

RefSeq Acc Id:

XM_017025919 ⟹ XP_016881408

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,268,786 - 32,470,882 (-)	NCBI

Sequence:

show sequence

GACCGCGAGCGCGAGCAGCGGCGGCCGCCGAGGCGCGGGTGGTGCCGGTGGCGGCGGCGGGGGAGCGCGGGACAGGAGGCTTCGGGGAAGATGGACCCGGCGCCCTCGCTGGGCTGCAGCCTCAAGGA
TGTGAAGTGGAGCTCGGTGGCCGTGCCGCTCGACCTCCTGGTCAGCACTTACCGGCTGCCCCAGATCGCGCGCCTGGACAACGGAGAGTGCGTAGAAGGGCTGCGGGAAAATGACTATCTGCTGATTC
ATTCCTGCCGCCAGTGGACCACCATCACTGCCCACAGCTTGGAGGAGGGTCACTATGTCATTGGGCCAAAGATAGAGATTCCGGTACATTATGCAGGGCAATTCAAGCTGCTGGAACAAGACCGAGAT
ATAAAGGAGCCAGTGCAATATTTCAACAGTGTGGAGGAGGTGGCTAAGGCATTTCCTGAACGCGTGTACGTCATGGAGGATATCACATTCAACGTGAAGGTTGCTTCAGGTGAATGCAATGAAGACAC
TGAAGTTTACAACATCACCCTGTGTACTGGGGATGAACTCACTCTAATGGGGCAGGCAGAAATCCTTTATGCAAAGACATTCAAGGAAAAGTCACGACTCAACACAATCTTCAAAAAGATTGGGAAGC
TCAATTCCATCAGCAAGCTGGGAAAAGGCAAAATGCCGTGCCTCATTTGTATGAATCACCGGACCAACGAAAGCATTAGCCTTCCATTCCAGTGCAAGGGCAGATTTAGCACCCGAAGTCCCCTGGAA
CTTCAGATGCAAGAGGGCGAACACACCATCCGCAACATTGTGGAGAAAACCAGGCTTCCTGTGAATGTGACTGTGCCAAGCCCTCCACCGAGAAACCCATACGACCTCCACTTCATCCGTGAGGGGCA
CCGCTATAAGTTTGTGAACATCCAGACCAAGACGGTGGTGGTTTGCTGTGTGCTGCGGAACAACAAGATCCTCCCCATGCACTTTCCTTTGCACTTGACTGTCCCCAAGTTCAGCCTCCCAGAACACC
TGGTGAAGGGAGAGAGCTGGCCCGAAACCCTGGTCCATCACTGGCTAGGTATCTGCCAAGAACAGTTCGACATCGATGAGTATTCACGGGCTGTCCGTGATGTGAAAACCGACTGGAATGAAGAATGC
AAGAGCCCCAAGAAGGGTCGGTGCTCTGGCCACAACCACGTGCCCAATTCGCTCAGCTACGCCCGCGATGAGCTCACCCAGTCCTTCCACCGACTCTCGGTCTGTGTGTATGGCAACAATCTCCATGG
CAACAGTGAGGTGAACCTTCATGGTTGCAGGGACCTGGGGGGAGATTGGGCTCCCTTTCCTCATGACATCCTGCCCTATCAGGACTCTGGAGATAGTGGGAGCGACTACCTTTTCCCAGAAGCTAGTG
AAGAATCAGCAGGCATCCCGGGAAAGTCAGAACTTCCCTACGAAGAGCTGTGGCTGGAGGAAGGCAAGCCCAGCCATCAGCCTCTCACTCGCTCTCTGAGCGAGAAGAACAGATGTGATCAGTTTAGA
GGTTCTGTCCGATCCAAATGTGCGACTTCTCCTCTTCCCATCCCTGGGACTCTGGGAGCAGCAGTGAAGTCTTCAGATACTGCCCTACCTCCACCTCCAGTGCCTCCCAAATCTGAAGCCGTCAGAGA
AGAATGCCGGCTCCTGAACGCCCCACCTGTTCCACCCCGAAGCGCAAAGCCTTTGTCCACCAGTCCCTCCATCCCTCCTCGCACAGTCAAGCCAGCGCGGCAACAGACTCGCTCTCCCAGCCCCACCT
TGTCCTACTATTCTTCAGGGCTACACAACATAATGGAAGAGCCAATGTCTTGGGAAGAAAAGATGCCACACCAGTCTGAGAAATTCAGAGGTAAAGGCCAACTAGATTCTCCTGGAAACAACCCGGGG
GCTGCCATCAGTTCTCACAAGTCAGCATCTGGTTCTTTCCACTTTGACACGAGCAGACAGCACCTTCAAGCAGACAACACCTTCGACCAGGACCTAAAATGGAAAGGGTCCCATTGGCTATCTACTCT
GAATTTCCATCCAGACAGGAGTCCCCTTTTGACCATCACTGTTGAGTGGTCATTTCCTTTTGTCTGGATACTTCCAGTGCTCTGAGATCATTCTTCTGCAACACAGCTCATTCCATTGTTGGCAAGTA
CCAATACTTAAAAAAAAACACCCTTTATTATATTGAGTTGAAATCAACCTCTGTGTAACTTTCAATCATTTCTTAGGTCTAAAGAAACAAAAATAGGTCCATCCCATATCTCTTTGTCAACTCATGAA
AATTCCGAGTCAGCTATGATAGAAGTCTTCTCTTCTCCAAAAGAAACATCCTTGCGTCCCTCTACTGTTTCCCCGACATCACTGTCAGACCCCTCACCGGCCTGCTCACCCTCCTTTGAGCACACTCT
AGTTTCATGTTGCTCTTAAAACCCCCCAGAGCCTAAGCTACCGCTCCACATGTGCTCATTACAGTTTAAAGTAGCTCTCTTTGCAGGTACTTTTTGTTCTCTGGACATTTAAATCTTTGCGCTAATGT
TACTCGATTGTTCAGAAACTAAGACAAGGATAAACATTTTATTTGAAGGATTTCCTCCTGCCTCAGACTTTTGGGTGGAAATAGAGTCACGGGTGGTGTGATGCCATCATGTCACTGTAGCACAAGCA
TGGCAAGCATGCGCCACTCATTTACTATTCTCTCCTTCTACCCTCGCTCACTGCAGACATCATTCATCAATCATGGCACCTGTTGGTGCAGAGCCTACACGTGACTTAATAATTTTCCTCATCATAAA
GATCCAGGCACCTATTAACAATTATTTTCTTACTAGCTGAAATATTTATTTTATCTCCACTGTAGCATTTTAAATCATTATGTACATATCTACAATTACCAATGTATTTTATTAAAGATTCTTTAAAA
AAAAAACCCAGTGAAGTTAGCAGGAATTTTATTGAATTCAAAACTAACTGCGCTTTTCTACTCAGCAGTAACGTCTATAAATAACAAAAGCCTTGGGATTTGGCTTTTTTCTTTTAACTGATTTCTCC

hide sequence

RefSeq Acc Id:

XM_024451234 ⟹ XP_024307002

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,263,522 - 32,420,891 (-)	NCBI

Sequence:

show sequence

GTAGATGCAGCGCAGATACTGAGGAAGGAACTCCAGCTGCTGCATAAGTGAGAACAGTCTGAGGTGCCGCAAGATTGTTGGATTCTCTGTAATGAAGACAGAGCCACGGCAGAGAACGTTCATGTTTA
TGAAACCAATGCAGAGAGTGCGTAGAAGGGCTGCGGGAAAATGACTATCTGCTGATTCATTCCTGCCGCCAGTGGACCACCATCACTGCCCACAGCTTGGAGGAGGGTCACTATGTCATTGGGCCAAA
GATAGAGATTCCGGTACATTATGCAGGGCAATTCAAGCTGCTGGAACAAGACCGAGATATAAAGGAGCCAGTGCAATATTTCAACAGTGTGGAGGAGGTGGCTAAGGCATTTCCTGAACGCGTGTACG
TCATGGAGGATATCACATTCAACGTGAAGGTTGCTTCAGGTGAATGCAATGAAGACACTGAAGTTTACAACATCACCCTGTGTACTGGGGATGAACTCACTCTAATGGGGCAGGCAGAAATCCTTTAT
GCAAAGACATTCAAGGAAAAGTCACGACTCAACACAATCTTCAAAAAGATTGGGAAGCTCAATTCCATCAGCAAGCTGGGAAAAGGCAAAATGCCGTGCCTCATTTGTATGAATCACCGGACCAACGA
AAGCATTAGCCTTCCATTCCAGTGCAAGGGCAGATTTAGCACCCGAAGTCCCCTGGAACTTCAGATGCAAGAGGGCGAACACACCATCCGCAACATTGTGGAGAAAACCAGGCTTCCTGTGAATGTGA
CTGTGCCAAGCCCTCCACCGAGAAACCCATACGACCTCCACTTCATCCGTGAGGGGCACCGCTATAAGTTTGTGAACATCCAGACCAAGACGGTGGTGGTTTGCTGTGTGCTGCGGAACAACAAGATC
CTCCCCATGCACTTTCCTTTGCACTTGACTGTCCCCAAGTTCAGCCTCCCAGAACACCTGGTGAAGGGAGAGAGCTGGCCCGAAACCCTGGTCCATCACTGGCTAGGTATCTGCCAAGAACAGTTCGA
CATCGATGAGTATTCACGGGCTGTCCGTGATGTGAAAACCGACTGGAATGAAGAATGCAAGAGCCCCAAGAAGGGTCGGTGCTCTGGCCACAACCACGTGCCCAATTCGCTCAGCTACGCCCGCGATG
AGCTCACCCAGTCCTTCCACCGACTCTCGGTCTGTGTGTATGGCAACAATCTCCATGGCAACAGTGAGGTGAACCTTCATGGTTGCAGGGACCTGGGGGGAGATTGGGCTCCCTTTCCTCATGACATC
CTGCCCTATCAGGACTCTGGAGATAGTGGGAGCGACTACCTTTTCCCAGAAGCTAGTGAAGAATCAGCAGGCATCCCGGGAAAGTCAGAACTTCCCTACGAAGAGCTGTGGCTGGAGGAAGGCAAGCC
CAGCCATCAGCCTCTCACTCGCTCTCTGAGCGAGAAGAACAGATGTGATCAGTTTAGAGGTTCTGTCCGATCCAAATGTGCGACTTCTCCTCTTCCCATCCCTGGGACTCTGGGAGCAGCAGTGAAGT
CTTCAGATACTGCCCTACCTCCACCTCCAGTGCCTCCCAAATCTGAAGCCGTCAGAGAAGAATGCCGGCTCCTGAACGCCCCACCTGTTCCACCCCGAAGCGCAAAGCCTTTGTCCACCAGTCCCTCC
ATCCCTCCTCGCACAGTCAAGCCAGCGCGGCAACAGACTCGCTCTCCCAGCCCCACCTTGTCCTACTATTCTTCAGGGCTACACAACATCAGCGTCACTAAAACTGACACAAATCCTTCTGAAAGCAC
TCCTGTTTCCTGCTATCCATGTAACCGAGTGAAAACTGATTCTGTGGACCTGAAATCCCCGTTTGGAAGTCCTTCTGCTGAAGCTGTGTCCTCTCGGCTCTCATGGCCTAACCATTATTCAGGAGCAT
CAGAAAGCCAGACCAGGAGTGACTTCCTGCTGGATCCAAGCAGGAGTTATAGTTACCCTAGACAAAAGACGCCAGGCACACCAAAGAGAAACTGCCCAGCACCTTTTGATTTTGATGGCTGTGAGCTC
CTGGCCAGCCCCACTAGCCCAGTCACTGCAGAATTCAGTAGCAGCGTCTCTGGTTGTCCCAAGTCAGCCAGCTACTCTCTGGAGAGCACAGATGTGAAATCTCTTGCAGCTGGTGTGACAAAGCAGAG
TACGTCATGCCCTGCCTTACCCCCCAGGGCTCCAAAACTAGTGGAAGAGAAGGTCGCCTCCGAAACATCTCCTTTGCCTCTGAAAATTGATGGTGCTGAGGAAGACCCCAAGTCTGGGTCACCAGATC
TCTCGGAGGACCAGTATTTTGTTAAAAAGGGCATGCAGGACATCTTCTCTGCCTCCTACCCTTTCTCATCTCCGCTCCATCTCCAGCTGGCCCCCAGATCCTGTGGCGACGGTTCCCCATGGCAGCCA
CCTGCTGACCTATCAGGACTCTCTATAGAGGAAGTGTCCAAGTCACTACGGTTCATTGGTTTGTCCGAAGATGTCATATCATTCTTTGTTACTGAAAAGATTGATGGGAACCTGCTTGTTCAGCTAAC
GGAAGAAATCCTCTCAGAGGATTTCAAATTGAGCAAATTGCAGGTGAAGAAGATAATGCAATTCATTAATGGCTGGAGGCCCAAAATATAGCCAAATAACCCCCGGCCAGCATGGAACAAAACTGATC
AATGCGTGTGCTAGAAGGGGTGGGCTGGGACACAATTTCATGTTTTTGCACTAAAAACCTTCTCTGTAAATAGGGATAAGAGAAACTCTTACTATGCAGATTACGTTTTTGAATGGTGAACAGGCTAT
TTTGTACATCAATAAAAATGCTGTACAGAACACTTGGAGGTGTGCCTTGTACGTCACTCAACAAACACTCAGCAGCTGCTAAAAGAAAAAAAGGCATGTGCAGAGAAATCATTCTTACCCAAGTAGGT
TTATGTGAGAAGGTATGATATTTATTACAAAATAGCCAAAGCTGGAAGACATAAAAATCTTTAAAAAAAAAAAAAAAACACTTTTGAACAAGTCCCTTCTTTCAGGAGGGTTGACTTTAGACAATTAA
CTGTGTTCTGTGCTCTGTCATTCAGATTGCTTCTTGCTAATTGTTTTACTCTTGTGCCTGAAAATGTTAGTGATACGAATTGACACTTTAATGTTGTATGCTTGGTGGGGATCTTTTTATCACAAGGC
ATTTTCCAAGAGTCATATGTTGATAAAGGGATATATGTTGTCCTTAGAAATCACACAAATCATGACCACAATAATTTATCTGTAACTGCTGCTAATTTTATTGAGCAGAGAAAAAAGAATATACATAT
ATAAACATGTATAGGTGCATACACAATACACCCGGATATGTTTTACACATAATTTTGATTCTGATATTTTAGATAACATCTGTTCACTTTTAAACAATCTGTTGAGGTTTTGGGACTGTTATCTACAT
TGATTCTCTTAGGAATAGTGGACAGAATGACTCCAAAGATTCTCAGAACCCTGTCTCTTGAAGCTCAATCTTATTTGGGTTCATCACTGAAAACTTAGAACAAATCAGTAAAGAATCCTGTATTGAAG
AATTAAGTTTGAGTTTAAGCCCACTCACCGCAGGGCTGGTTTTTGCATGTAATACTCCCATGATGTCTGGGGAAATGACAGTTTCTGTTGAATTATAATTCTCCGGTTTAAGGGTCTCCTTCCCCTGG
TGTCTGATGGTGAGAGGTCTGAAGAGCATTTGTCAGAGTACATTAGGCATTCTCAACCTACTTCATGCTTTACGAGAGCTGAGAAATCAGACGCACCGGCCTTTATTATTATATATGCTACATCTGTT
GAGTATTTTTAAAATACCAATAAGAGGACTTGTTTATTTCATAAACCACTTCTTCCCTCTCTTTCAAAGAAAATACATTATTACCATACTTTTACATTAGTCTGAGAATTTTTGCTAAATATGATTAA
GTATTCCAAAATATAATGGCGTCATTATTCTTGACTTTTTTAGAGAATATACATCTTAAGACTGTATTAGTTCTCAGAGCAAGGCATCATCTACTCCCCTGCACCTGAGAGTCTGGCCCCAGATTCCA
GATGTGCGGACAGCCCATGACCGAGGTGCACACAGTGCCCTCTTGAATAGGAAGGTCAGCCAGTGAGGCGGCAGCATAACTTGCAGGATGGACTTATATCTTACCATCTCTTCCTGCTACCAAAATAA
AAAAATAAATTGAAAGACAAGACCCACCAGTCTAGTTTTGTAGACCTGTGAAATGTGTCTTTATTTCTTGGCATTAGAAGAAAGATATTTTTAATCCATATCGTGGTTTTAGAGTTGAAGTGAATTGA
TACCCAATTTTCCATCTTAGATCTCCTTTATCAAAAAAAAAAGCATTTTTTTTCTCCTAACGTGTCTCCCAAAATGTAAATACTATAGGCAAAAAGAGTACCCTGTAAAATTCTCACACTGGAGCACC
TCTTCAAAAGTCACAGATAACTCAATGAGGAAGTGCTGGTACTGCACTCACAGGACATGAGACCTATGAAGCTTTCGTGTTTTGAAAGCATCCTTCTGTGTGAGGGGGACTGCCTCCCTTAGTAAAGT
AAACCTCTCAGAACTTCTTTTTAAAATAAAAACAGACAAGATGCAGTTACTAAGCTGCAAGTTTTCATTGGCAAACCTAGCTGAATCCGTTTTAAAATACTTAGCACTCGGACACAATTCTCAAACTC
AGGAAGAAGGAACAGGGTTGGTTTGGGTTTACTATAAAGGTTGCCTCACATAAACAACTGACTCCTTTTAGCGTTTTTTTTCTTTTTGTAAAAACTTTACACAAAATAGGGTTTTAAATTCTTTTTGC
TTGTTTTGGACTTGGTGTATTTTTGTCAAGTTTATATTGATTGGCAACGCAGAGACTCCTTGAGGGCAGGGACTGTGGCCTTTGATTCACTTATGCTACAGTCTAGTATCACTACAGTGCTGAGTAAA
AGACACAGCCCCTGCCCTCTTGGAGATCATATTGTTTATATTTGAAATCTCAGTTGCTAAGAGTATGTATGTGTGAGTAAGAAAGACGTGAAGTCCTATGGGCAGCTGGGTATATGGAGAATTACGTG
TGTCCTGTCTTTAAAACGTCAGCCTCTATTAAGGGGTACAGAACACCCCAAGATCACTAAAACTTGGAATGTGTTGGAGGCAGAAAGTATCTCTCTCATTGCCTAGTGTTGTTGTTTTTTTGTTTTTT
GTTTTTTGTTTTTTTTACTGACCTGGAATTCTTTTAATTGTAATAAATATCTTCTGTCACAAATAAATGCCACAAATAAATGAAATTGCCATTCCTAAGCTGAGCACCTGTCTGTGAAGGACCTTGGT
GTCCTGACTGGACAGAGCATTCATAGCTCCAAGAGAATCATGACAAGATATGCAAAGCAGGGATAATAAGGAGAAAGCCCTTCCCTTTCGAGAAGCCCTTCCCTTTCACAGCCCTTCCCTGCGATTCT
GCAGTGAAAAGTGATGCCCAGAGATCCACACACAGAACCCTTCTAACCAGCCAGGTCAAGACTTATCATCTTATCTCCTCTGGCAGGTCCCCTGTAATCAAAAGAGAGGAAGTGTCTATCTAAACAAG
ACCCTTTTGGGTCCTTAGATTCATGGCAAAAATCATCATGGCCCCCATCAGAAAAGAAAATCAGCAATAAACCAAGCCAAGCAACTAAAATGTATAATGTGGACCTGACTCATGTTGGGAGGCAGAAT
TCAGACACTCACAGATCAATCTTGCAAGTTTTCTCTTCTTTAAGTTGAGCTGCTCAACTTTATGAACTGTGAAATTTACTTACATTCTTTCAACCCACATATATCATTGCAGTTTATGAAGTTGCAGT
GAACTGCCCATTCAGCTAAATTGCAGTGTTTATTCTTGTCTCATGTCGAAATACAACAATCTTATGGGAAATATTATGACAGTCCGTTCCAACTGTTCTCAGACACATGCATAAACAGTCTCTGCTCA
CATTCCACAGCCACCTGCATGTTATCCATACAGCTCCCTGAGAAGTCCAGGGATGGGAGGTGGGGTGTGGAAGGATGGAGGGTCCTTCATTTTCTAAACACTTTGTATAAGTCACTACTCATCGTGCC
TAGCAAGTATAAGATTAACATTTTGAATAACAAACTGGAAAACAAATAATCCTTCAAAGAACCTAGCGAACTGTTCAAAGGAAATTTTAATTTCAGTCTACCAGAAAAGTTAAATCTGTTGTTGGACG
TAGGGGGCTTTCAGAAACATGCCTCTTATATCAATTTCCACTATCTTTCAAGTTACCTAAAGGCACCAGGCTGCTTGAGCAAGAAGAATAAAAGGCCTAGAGTGCAAATTATGTGAAGTAGAGTTTTT
AGATTGTGGGATTGTAATAATACGGGATTCTCATGGTTACATCATGTTAAATCACACTGTTCAGTCTTTAAAACTTGGTGTTTTAAAATTTGTCTCATTGTGATAGCCAGAAACAAGGAATAAACGTG
ATTTCAGTTTAAACTATATACAAATATCTTCTGTAATTTTGCTGCTCTAATTTTTAGGCTATAAATTTTGTAATAGAGCTTATCAGATCGCAAATTTCCTTTGTTTACAATCTCATGTAGTAGGGCTC
AGATAATTTCTTAGCTATAAACCTTTTCTCCCACTCTCATATTGTTTCATTTAAAATATTTAAGCTAAGCCTAAAAATTGAAATCAGTTAAGAATTTGGAGAGTTTATCTTAAATGGAAATGGTGTAT
TCTTTTCAAAGAATTTTGTAACCATCTTTACAGTTTCTTTGCTTGGAAAACTTGGGTTGTTAACTACCAGTTAACAATGGCATTACTTTCCAAAACGTTATCTAATGGGCCCAATGTGTACCTCAAGA
TAAACACAGTATGTTATGTCTAAAAATTTCCTTGTCTGTTGATTTAAATGGTTCTGAAATGTCTGTAATAAAGAAATTTTCAAAGTTGC

hide sequence

RefSeq Acc Id:

XM_047437739 ⟹ XP_047293695

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,263,522 - 32,393,000 (-)	NCBI

RefSeq Acc Id:

XM_047437740 ⟹ XP_047293696

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,263,522 - 32,363,903 (-)	NCBI

RefSeq Acc Id:

XM_054318978 ⟹ XP_054174953

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	18	32,453,815 - 32,611,197 (-)	NCBI

RefSeq Acc Id:

XM_054318979 ⟹ XP_054174954

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	18	32,453,815 - 32,583,306 (-)	NCBI

RefSeq Acc Id:

XM_054318980 ⟹ XP_054174955

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	18	32,453,815 - 32,554,202 (-)	NCBI

RefSeq Acc Id:

XM_054318981 ⟹ XP_054174956

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	18	32,459,079 - 32,661,186 (-)	NCBI


Protein RefSeqs	NP_001229338	(Get FASTA)	NCBI Sequence Viewer
	NP_073588	(Get FASTA)	NCBI Sequence Viewer
	XP_016881408	(Get FASTA)	NCBI Sequence Viewer
	XP_024307002	(Get FASTA)	NCBI Sequence Viewer
	XP_047293695	(Get FASTA)	NCBI Sequence Viewer
	XP_047293696	(Get FASTA)	NCBI Sequence Viewer
	XP_054174953	(Get FASTA)	NCBI Sequence Viewer
	XP_054174954	(Get FASTA)	NCBI Sequence Viewer
	XP_054174955	(Get FASTA)	NCBI Sequence Viewer
	XP_054174956	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH05074	(Get FASTA)	NCBI Sequence Viewer
	AAI21068	(Get FASTA)	NCBI Sequence Viewer
	AAI21069	(Get FASTA)	NCBI Sequence Viewer
	BAB15094	(Get FASTA)	NCBI Sequence Viewer
	BAG59858	(Get FASTA)	NCBI Sequence Viewer
	CAD39149	(Get FASTA)	NCBI Sequence Viewer
	EAX01286	(Get FASTA)	NCBI Sequence Viewer
	EAX01287	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000269209
	ENSP00000269209.6
	ENSP00000382165
	ENSP00000382165.3
GenBank Protein	Q9H706	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_073588 ⟸ NM_022751
- Peptide Label:	isoform 2
- UniProtKB:	B4DME6 (UniProtKB/TrEMBL)
- Sequence:	show sequence MDPAPSLGCSLKDVKWSSVAVPLDLLVSTYRLPQIARLDNGECVEGLRENDYLLIHSCRQWTTITAHSLEEGHYVIGPKIEIPVHYAGQFKLLEQDRDIKEPVQYFNSVEEVAKAFPERVYVMEDITF NVKVASGECNEDTEVYNITLCTGDELTLMGQAEILYAKTFKEKSRLNTIFKKIGKLNSISKLGKGKMPCLICMNHRTNESISLPFQCKGRFSTRSPLELQMQEGEHTIRNIVEKTRLPVNVTVPSPPP RNPYDLHFIREGHRYKFVNIQTKTVVVCCVLRNNKILPMHFPLHLTVPKFSLPEHLVKGESWPETLVHHWLGICQEQFDIDEYSRAVRDVKTDWNEECKSPKKGRCSGHNHVPNSLSYARDELTQSFH RLSVCVYGNNLHGNSEVNLHGCRDLGGDWAPFPHDILPYQDSGDSGSDYLFPEASEESAGIPGKSELPYEELWLEEGKPSHQPLTRSLSEKNRCDQFRGSVRSKCATSPLPIPGTLGAAVKSSDTALP PPPVPPKSEAVREECRLLNAPPVPPRSAKPLSTSPSIPPRTVKPARQQTRSPSPTLSYYSSGLHNIVTKTDTNPSESTPVSCYPCNRVKTDSVDLKSPFGSPSAEAVSSRLSWPNHYSGASESQTRSD FLLDPSRSYSYPRQKTPGTPKRNCPAPFDFDGCELLASPTSPVTAEFSSSVSGCPKSASYSLESTDVKSLAAGVTKQSTSCPALPPRAPKLVEEKVASETSPLPLKIDGAEEDPKSGSPDLSEDQYFV KKGMQDIFSASYPFSSPLHLQLAPRSCGDGSPWQPPADLSGLSIEEVSKSLRFIGLSEDVISFFVTEKIDGNLLVQLTEEILSEDFKLSKLQVKKIMQFINGWRPKI hide sequence

RefSeq Acc Id:	NP_001229338 ⟸ NM_001242409
- Peptide Label:	isoform 1
- UniProtKB:	Q8ND03 (UniProtKB/Swiss-Prot), Q0VAG4 (UniProtKB/Swiss-Prot), Q0VAG3 (UniProtKB/Swiss-Prot), Q9BSF5 (UniProtKB/Swiss-Prot), Q9H706 (UniProtKB/Swiss-Prot), B4DME6 (UniProtKB/TrEMBL)
- Sequence:	show sequence MDPAPSLGCSLKDVKWSSVAVPLDLLVSTYRLPQIARLDNGECVEGLRENDYLLIHSCRQWTTITAHSLEEGHYVIGPKIEIPVHYAGQFKLLEQDRDIKEPVQYFNSVEEVAKAFPERVYVMEDITF NVKVASGECNEDTEVYNITLCTGDELTLMGQAEILYAKTFKEKSRLNTIFKKIGKLNSISKLGKGKMPCLICMNHRTNESISLPFQCKGRFSTRSPLELQMQEGEHTIRNIVEKTRLPVNVTVPSPPP RNPYDLHFIREGHRYKFVNIQTKTVVVCCVLRNNKILPMHFPLHLTVPKFSLPEHLVKGESWPETLVHHWLGICQEQFDIDEYSRAVRDVKTDWNEECKSPKKGRCSGHNHVPNSLSYARDELTQSFH RLSVCVYGNNLHGNSEVNLHGCRDLGGDWAPFPHDILPYQDSGDSGSDYLFPEASEESAGIPGKSELPYEELWLEEGKPSHQPLTRSLSEKNRCDQFRGSVRSKCATSPLPIPGTLGAAVKSSDTALP PPPVPPKSEAVREECRLLNAPPVPPRSAKPLSTSPSIPPRTVKPARQQTRSPSPTLSYYSSGLHNISVTKTDTNPSESTPVSCYPCNRVKTDSVDLKSPFGSPSAEAVSSRLSWPNHYSGASESQTRS DFLLDPSRSYSYPRQKTPGTPKRNCPAPFDFDGCELLASPTSPVTAEFSSSVSGCPKSASYSLESTDVKSLAAGVTKQSTSCPALPPRAPKLVEEKVASETSPLPLKIDGAEEDPKSGSPDLSEDQYF VKKGMQDIFSASYPFSSPLHLQLAPRSCGDGSPWQPPADLSGLSIEEVSKSLRFIGLSEDVISFFVTEKIDGNLLVQLTEEILSEDFKLSKLQVKKIMQFINGWRPKI hide sequence

RefSeq Acc Id:

XP_016881408 ⟸ XM_017025919

- Peptide Label:

isoform X2

- Sequence:

show sequence

MDPAPSLGCSLKDVKWSSVAVPLDLLVSTYRLPQIARLDNGECVEGLRENDYLLIHSCRQWTTITAHSLEEGHYVIGPKIEIPVHYAGQFKLLEQDRDIKEPVQYFNSVEEVAKAFPERVYVMEDITF
NVKVASGECNEDTEVYNITLCTGDELTLMGQAEILYAKTFKEKSRLNTIFKKIGKLNSISKLGKGKMPCLICMNHRTNESISLPFQCKGRFSTRSPLELQMQEGEHTIRNIVEKTRLPVNVTVPSPPP
RNPYDLHFIREGHRYKFVNIQTKTVVVCCVLRNNKILPMHFPLHLTVPKFSLPEHLVKGESWPETLVHHWLGICQEQFDIDEYSRAVRDVKTDWNEECKSPKKGRCSGHNHVPNSLSYARDELTQSFH
RLSVCVYGNNLHGNSEVNLHGCRDLGGDWAPFPHDILPYQDSGDSGSDYLFPEASEESAGIPGKSELPYEELWLEEGKPSHQPLTRSLSEKNRCDQFRGSVRSKCATSPLPIPGTLGAAVKSSDTALP
PPPVPPKSEAVREECRLLNAPPVPPRSAKPLSTSPSIPPRTVKPARQQTRSPSPTLSYYSSGLHNIMEEPMSWEEKMPHQSEKFRGKGQLDSPGNNPGAAISSHKSASGSFHFDTSRQHLQADNTFDQ
DLKWKGSHWLSTLNFHPDRSPLLTITVEWSFPFVWILPVL

hide sequence

RefSeq Acc Id:	XP_024307002 ⟸ XM_024451234
- Peptide Label:	isoform X1
- UniProtKB:	B4DME6 (UniProtKB/TrEMBL)
- Sequence:	show sequence MEDITFNVKVASGECNEDTEVYNITLCTGDELTLMGQAEILYAKTFKEKSRLNTIFKKIGKLNS ISKLGKGKMPCLICMNHRTNESISLPFQCKGRFSTRSPLELQMQEGEHTIRNIVEKTRLPVNVTVPSPPPRNPYDLHFIREGHRYKFVNIQTKTVVVCCVLRNNKILPMHFPLHLTVPKFSLPEHLVK GESWPETLVHHWLGICQEQFDIDEYSRAVRDVKTDWNEECKSPKKGRCSGHNHVPNSLSYARDELTQSFHRLSVCVYGNNLHGNSEVNLHGCRDLGGDWAPFPHDILPYQDSGDSGSDYLFPEASEES AGIPGKSELPYEELWLEEGKPSHQPLTRSLSEKNRCDQFRGSVRSKCATSPLPIPGTLGAAVKSSDTALPPPPVPPKSEAVREECRLLNAPPVPPRSAKPLSTSPSIPPRTVKPARQQTRSPSPTLSY YSSGLHNISVTKTDTNPSESTPVSCYPCNRVKTDSVDLKSPFGSPSAEAVSSRLSWPNHYSGASESQTRSDFLLDPSRSYSYPRQKTPGTPKRNCPAPFDFDGCELLASPTSPVTAEFSSSVSGCPKS ASYSLESTDVKSLAAGVTKQSTSCPALPPRAPKLVEEKVASETSPLPLKIDGAEEDPKSGSPDLSEDQYFVKKGMQDIFSASYPFSSPLHLQLAPRSCGDGSPWQPPADLSGLSIEEVSKSLRFIGLS EDVISFFVTEKIDGNLLVQLTEEILSEDFKLSKLQVKKIMQFINGWRPKI hide sequence

Ensembl Acc Id:

ENSP00000382165 ⟸ ENST00000399218

Protein Domains

CABIT SAM

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9H706-F1-model_v2	AlphaFold	Q9H706	1-876	view protein structure

RGD ID:

6794872

Promoter ID:

HG_KWN:27852

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4

Transcripts:

OTTHUMT00000255364, UC002KXL.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	18	28,304,306 - 28,305,017 (-)	MPROMDB

RGD ID:

7237155

Promoter ID:

EPDNEW_H24323

Type:

initiation region

Name:

GAREM1_1

Description:

GRB2 associated regulator of MAPK1 subtype 1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	18	32,470,519 - 32,470,579	EPDNEW

Database	Acc Id	Source(s)
COSMIC	GAREM1	COSMIC
Ensembl Genes	ENSG00000141441	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000269209	ENTREZGENE
	ENST00000269209.7	UniProtKB/Swiss-Prot
	ENST00000399218	ENTREZGENE
	ENST00000399218.8	UniProtKB/Swiss-Prot
Gene3D-CATH	1.10.150.50	UniProtKB/Swiss-Prot
GTEx	ENSG00000141441	GTEx
HGNC ID	HGNC:26136	ENTREZGENE
Human Proteome Map	GAREM1	Human Proteome Map
InterPro	CABIT_dom	UniProtKB/Swiss-Prot
	GAREM	UniProtKB/Swiss-Prot
	SAM/pointed_sf	UniProtKB/Swiss-Prot
KEGG Report	hsa:64762	UniProtKB/Swiss-Prot
NCBI Gene	64762	ENTREZGENE
OMIM	617998	OMIM
PANTHER	GRB2-ASSOCIATED AND REGULATOR OF MAPK PROTEIN 1	UniProtKB/Swiss-Prot
	GRB2-ASSOCIATED AND REGULATOR OF MAPK PROTEIN FAMILY MEMBER	UniProtKB/Swiss-Prot
Pfam	CABIT	UniProtKB/Swiss-Prot
PharmGKB	PA134888032	PharmGKB
Superfamily-SCOP	SSF47769	UniProtKB/Swiss-Prot
UniProt	B4DME6	ENTREZGENE, UniProtKB/TrEMBL
	GARE1_HUMAN	UniProtKB/Swiss-Prot
	J3QRF3_HUMAN	UniProtKB/TrEMBL
	Q0VAG3	ENTREZGENE
	Q0VAG4	ENTREZGENE
	Q8ND03	ENTREZGENE
	Q9BSF5	ENTREZGENE
	Q9H706	ENTREZGENE
UniProt Secondary	Q0VAG3	UniProtKB/Swiss-Prot
	Q0VAG4	UniProtKB/Swiss-Prot
	Q8ND03	UniProtKB/Swiss-Prot
	Q9BSF5	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-11-24	GAREM1	GRB2 associated regulator of MAPK1 subtype 1	GAREM1	GRB2 associated regulator of MAPK1 1	Symbol and/or name change	5135510	APPROVED
2015-11-10	GAREM1	GRB2 associated regulator of MAPK1 1	GAREM	GRB2 associated, regulator of MAPK1	Symbol and/or name change	5135510	APPROVED
2012-12-04	GAREM	GRB2 associated, regulator of MAPK1	FAM59A	family with sequence similarity 59, member A	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar